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(Under the direction

of DR. GABRIEL VlRELLA.)

The increasing incidence of systemic candidiasis and

the difficulties with diagnosing the disease on the basis
of clinical data and culture results have prompted investigation into

i~~unological

methods of diagnosis.

Detection

of anti-candida antibodies has proved to be not sufficient-

ly specific for

~iagnosis

of systemic disease since anti-

bodies are frequently found in the normal individual in
whom the organism lives as a commensal and in superficially
infected individuals.

Our project

result~d

in the develop-

ment of a new quantitative immunofluorescence assay for
quantitation of anti-candida antibodies which is able to
differentiate quite well (p < 0.0005) between systemically
infected patients and normals or superficially infected
patients.

We have also investigated the value of purified

antigel1s and have shown that the use of cytopla.smic protein

antigens rather than those containing cell wall polysaccharide confers greater specificity on a

q~alitative

test for

anti-candida antibodies but that a carbohydrate-containing

antigen is adequate for differentiating systemic disease
when a

~uantitative

test is used.

Attempts to diagnose systemic candidiasis by detection

iii

of circulating antigen have met with varying degrees of

success.

We were unable to detect antigen by counterirnmu-

noelectrophoresis, a quantitative immunofluorescence inhibition assay, or an ELISA inhibition assay in the sera of
rabbits in whom a Candida endocarditis was induced or in
the sera of systemically infected patients.

One postulated

reason for this failure is the presence of the antigen in
t.he form of circulating lmmune complexes.

We have, tllere-

fore, investigated the possibility of the existence of complexes containing Candida antigen and antibody in the sera
of patients with systemic candidiasis.

Using four screen-

ing tests, a statistically significant difference (p < 0.05)
was found for immune complex levels in a group of patients
and a group of normal individuals.

Isolation and charac-

terization of immune complex-containing fractions from five
patients with candidiasis indicated the presence of antiCandida antibodies and/or antigen in at least three of then).
Therefore, these fungal

in~une

complexes can be assumed to

exist and may play a role in the difficlll ties in detecting

circulating antigen and, furthermore, may be involved in
the pathogenesis and progression of disseminated candidia-

.

s~s.
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Introduction

The clinical conditions now known to be caused by the
organism Candida albicans ha\7e been recognized for centu-

ries.

Hippocrates described Iraphthae lt or white patches in

debilitated pa.tients in llis "Epidemics II and the disease
"thrush" was noted in Pepyst diary in 1665 (1).

The oral

lesion was recognized early as a condition of the newborn
as well as of the debilitated and Veron in 1835 postulated
that it was acquired during passage through the womb.

Vag-

inal candidiasis was first described by Wilkinson in 1849
and systenlic disease, acquired by hematogenous spread, was

described by Zenker in 1861 (2).
In 1839, Langenbeck (3) described a fungus in aphthae

but he did not consider the fungus to be related to the

disease.

However, Berg in 1841 and Bennett (4) in 1844

conclusively delnorlstrated the fungal etiology of thrush.

Bennett recognized the dimorphic nature of the organism and
irl 1847 Robin placed it in thelfgenus Oidium under the name

oidium albicans (2).

He

described in detail the egg-

shaped, oval yeast cell and the mycelial form of th.e fun-

gus.

In 1890, Zopf described a similar organism as Monilia

albicans bringing confusion to the nomenclature of the
yeast (2).

Finally, in 1923 Berkhout clear'ed up the confu-
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sian in assigning the generic designation Candida to those
fUIlgi which developed a pseudornycelium and reproduced by

budding (5).
Today, 81 species of Candida have been recognized.
Most live as commensals in llumans, representing part of the
normal flora of cutaneous and mucocutaneous areas.

The

most commonly encountered pathogenic species is Candida
albicans.

It is a small oval, budding, yeast-like fungus,

2.5 by 4 by 6

~rn,

which develops a pseudomycelium by elon-

gation of cells which fail to detach (6).

In sputum, tis-

sue and exudates both the budding cells and fragments of
pseudomycelia may be seen.

Other species including

c. parapsilos, c. tropicalis, c. stellataidea, and
c. guillermondi, are of more limited pathogenicity, although they may be isolated in some of the less common but
frequently more severe clinical manifestations of candidia-

.

SlS.

Candida albicans is a

no~~al

i~~abitant

of the alimen-

tar)1 tract al1d the mucocutaneous regions in man.

It i.s

regularly present in small numbers in the mouths of normal
healthy adults and can be found in the normal vagina of
healthy non-pregnant women with an incidence of about 5%
(7).

The gastro-intestinal tract has a small but constant

population of

c.

albicans, the number being influenced by

the diet of the individual and by the presence of other
members of the intestinal flora.

Normal skin less cornmonly

harbors a resident flora of c. albicans, but almost any
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damage to skin or environmental change leads to rapid colonization (8).
In the normal host, control is maintained such that the
number of organisms inhabiting these sites remains small
and clinically insignificant.

The balance between commen-

sal and host, however, is delicate and can be easily upset
leading to overgrowth and to potential pathogenicity of the
organism.

Poor oral hygiene or even a small amount of an-

tibiotics may promote an increase in the number of organisms in the mouth.
untoward results.

In the adult this is usually without
In the newborn"however, before an oral

ecology is established and where a low pH in the mouth may
promote proliferation of the organlsm, even a few organisms
presage clinical thrush (9).

In older children, chronic

thrush usually indicates polyendocrine disturbances or an
underlying defect in natural defenses.

In adults, signifi-

cant oral infection may occur as a result of mild avitaminosis or as a complication of diabetes mellitus, advanced
neoplasia, or the administration of steroids, antibiotics,
or other drugs (9).
In gravid women there is a distinct increase in clini-

cal Candida vaginitis.

Pregnancy appears to affect the

carbohydrate content of the vagina and this promotes overgrowth of tIle organism.

Diabetes and antibiotic thera.py

may also predispose to vaginal candidiasis.

Candida

balanitis or balanoposthitis may occur rarely in males,
most often w:here there is a history of vaginitis in the
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spouse and the condition is probably a conjugal infection
(9) .

It has been established that other members of the intestinal flora exert control over the population of

c.

al--

bicans in the lower intestinal tract through a number of
mechanisms such as production of inhibitory concentrations

of lactic acid and competition for available nutrients (1).
Overgrowth of yeasts may occur in the young before a bal-

anced flora is established and may be associated with
clinical symptoms such as a diaper rash following perianal
colonization (9).

In adults in whom orally administered

antibiotics have altered the intestinal flora, overgrowth
of the organism may lead to an irritating pruritis ani, destruction of the esophageal mucous membrane, or invasion of

the gastro-intestinal mucosa.

Other factors promoting

gastro-intestinal overgrowth of the organism are diabetes,

corticosteroid administration, irradiation, various neoplasias, blood dyscrasias, endocrinopathies and other debilitating conditions (10).
Overgrowth of

c.

albicans on the skin frequently in-

volves intertriginous areas such as the axillae, groin, intermammary fold, intergluteal folds, and interdigital spa-

ces.

I t may occur as a result of metabolic disorders or

environmental conditions such as moisture, occlusion, or
maceration of the skin.

Chronic mucocutaneous candidiasis

occurs in patients with genetic defects in the immune response and in patients with polyendocrine disorders (9).
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Besides these localized overgrowths of Candida in
sites where the

o~ganism

normally lives as a commensal, a

more significant imbalance in the forces which normally
prevent transition from commensalism to parasitism can lead
to dissemination of the organism to multiple internal sites
and to a potentially lethal systemic infection.

Develop-

ments in medicine since 1940 have greatly increased the occurrence of this imbalance of forces and the subsequent severe fungal infections.
with the onset of widespread use of antibiotics, in
particular broad-spectrum antibiotics, the delicate ecosystem of which Candida is a member may frequently be disturbed (10).

Not only do antibiotics suppress the normal

flora which acts as competition for the corrunensal Candida
organisms, but, in addition, some damaging action by antibiotics on the outer layers of mucous membranes, notably
of the intestinal tract, may facilitate the penetration of
the organism.

Should the host's resistance be impaired,

further invasion, dissemination, and severe

clini-c,~l symp-

toms may occur (11).
The use of steroid therapy, immunosuppressive drugs,
antimetabolites, and cytostatic drugs also affects the
balance between host and saprophytic orga11ism.

All of

these treatment modalities, which can improve the patient's
prognosis with respect to other disorders, may cause a significant abrogation of the body's defenses again.st invading

or proliferating fungal organisms.

Normally, the phagocy-

6

tic cells of the body are capable of ingesting Candida and
the cellular response to the invader is considered the most
important component of the defense.

The organs of the body

which have large numbers of histiocytes, for instance,

lungs, liver, and spleen, are relatively resistent to infection with Candida.

On the other hand, there is evidence

that when deep-seated Candida infections do occur, the cellular response is often sluggish or lacking.

Therefore,

therapy with those agents which decrease the numbers or
effectiveness of phagocytic cells in the body can lead to
systemic infection and dangerous clinical symptomatology
(12 ) •

The practice of modern medicine has seen a tremendous
increase in the number and extent of

in~,asiv'e

techniques

undertaken to provide the patient with greater length and
quality of life.

The common use of intravenous catheters

provides an easy entry into the body for organisms which
are normally found on the skin (13).

Hemodialysis and

peritoneal dialysis are procedures which also

brea~h

the

body's non-specific defenses and allow entry of normally
non~pathogenic

agents.

One important source of entry seems

to be 'the heart-lung machine, where Candida cells may
easily hide and escape the procedures of disinfection so
that on use of the machine, the fungi enter the systemic
circulation of the patient (14).

Postoperative antibiotic

prophylaxis after heart surgery can increase further the
likelihood that the invading Candida will ca.use dis semina-
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commensal Candida and the host has been upset and the fungus becomes invasive, the results can be disastrous for the
host.

The disease, when untreated, can be rapidly fatal

leading to death within a few days (18).

Taschdjian et

al., in a review, found the overall mortality rate in eight
t

studies containing 141 patients to be 75% (3).
Unfortunately, the advances in medicine which have
brought about the increased incidence of severe fungal Infections have not been accompanied by advances in the

treatment of these infections.

Drugs with a relatively

high therapeutic index, such as Ketoconazole and Mycostatin, have been developed for the treatment of mucocutaneous
infections; however, the drug of choice for disseminated
candidiasis is Amphotericin B which has a large number and
variety of untoward effects.

These include anaphylaxis,

thrombocytopenia, flushing, generalized pain, convulsions,
chills, fever, headache, phlebitis, anemia, anorexia

decreased renal function.

l

and

The most significant of these is

the impairment of renal function which occurs in
of persons given Amphotericin B (19).

o-;~er

80%

Amphotericin B must

be administered parenterally and requires hospitalization
and close observation throughout the period of therapy

which is usually 6-10 weeks.
,

Because of the increased il1cidence of severe Candida
infections and the frequency and severity of side effects
associated with the treatment of choice, a method of diagnosing systemic candidiasis is badly needed.

The physician
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needs help in making what is a difficult therapeutic decision because, on the one hand, unnecessary toxic therapy
should be avoided but, on the other, a delay in specific

anti-fungal therapy in the patient with disseminated disease cannot be afforded.

The problem is compounded by the

presence of Candida as a commensal and the frequent occurrences of "benign" overgrowth.

Differentiation between a

superficial and a systemic infection must be made in order
to come to a good therapeutic decision.
In too many cases, systemic disease is not diagnosed

until after death (20) since the diagnosis can be definitely made only on the basis of histologic studies of infected
tissue or autopsy findings.

Studies have shown that only

10-44% of cases of disseminated candidiasis documented at

autopsy were clinically suspected or diagnosed antemortem
(21).

Cultures of body fluids, which are a major means of

identifying other infecting organisms, are 'difficult to interpret in the case of candidiasis.

Part of this difficul-

ty stems from the ubiquitousness of the organism aL a

~C?m

mensal and the frequency of its occurrence as a superficial
pathogen.

A positive Candida culture from the oral cavity,

stool, or vagina is obviously of little diagnostic value
since so many individuals harbor the organism at these
sites (3).

In patients on antibiotics, Candida may prolif-

erate but the mere presence of large numbers of the organism does not necessarily indicate severe infection (20).
In a significant number of these cases either with the ad-
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ministration of antibiotics or with other predisposing
causes, a fungemia is felt to represent a transient contamination of the blood stream rather than seeding from a deep
focus of infection (22).

Indeed, Candida in blood cultures

from patients with intravenous catheters may, on occasion,
be eradicated by simple removal of the catheter (23).
Conversely, patients with disseminated candidiasis often have negative blood cultures (24).

This may be because

of rapid clearing of Candida from the blood by the liver
and spleen

~s

has been shown in mice (25).

Complement

seems to play a role in enhancing the killing of the organisms in other critical target organs such as the kidney
(26).
A diagnosis of systemic candidiasis on the basis of

clinical data is likewise difficult.

The manifestations of

dissemination of Candida include chills, high, spiking fever, hypotension, and prostration, none of which can be
considered etiologically specific (24).

One clue that may

indicate the possibility of sys·temic candidiasis is the
presence of numerous cotton-like candidal colonies on the
patient's oropharynx.

However, since such focal growth is

evident in patients without disseminated disease, it is only of inferential value (27).

Endophthalmitis is consid-

ered to be a pathognomonic clinical sign, but it is not always present (28).
Skin testing has also been investigated as a means of

identifying patients with candidiasis, but, since cellular
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hypersensitivity to Candida has been demonstrated in 45-80%
of persons without candidal infection, skin testing has
been largely abandoned as a means of diagnosing candidiasis
(3).

Another problem is the possibility of anergy in pa-

tients with overwhelming infection (29).
Because of these problems with diagnosing systemic
candidiasis on the basis of clinical data and culture results, there has been a great deal of interest over the
past years in the development of serological tests to be
used along with other information to reach a diagnosis.
The detection of antibodies in the. sera of patients with
suspected s:ystemic candidiasis has long been thought of as
a potentially rapid and valuable diagnostic method.

A num-

ber of different techniques of antibody detection have been
tried.
Direct slide or tube agglutination of particulate an-

tigen is one of the simplest serodiagnostic tests used in a
variety of infectious diseases and its usefulness has been
widely investigated with regard to candidiasis (29,30).
The result has been that, for several reasons, agglutinin

determinations are considered to be of little diagnostic
value.

Agglutinins have been found in the sera of 20% or

more of healthy individuals without evidence of candidal
infection, and there is frequent occurrence of cross-agglutination with other microorganisms.

In addition, complete

absence of agglutinating antibody or insignificant titers
have been reported in

som~

20-25% of patients with systemic
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candidiasis (3).

Increased sensitivity of agglutination

tests ·has been achieved using latex particles (31) or red
blood cells (32) coated with Candida antigen.

The classical complement fixation test has been used
in Candida serology but the test has been concluded to be
unreliable for clinical diagnostic use and, thus, is not
widely utilized today (33).
Precipitation tests have been widely used to detect

anti-candida antibodies.

A tube test used by Chew and

Theus (34) was shown to be highly sensitive but double dif£a-sI'orl

~'ll

a.gar geLs

rS-:5f

r1cU5

Deell

HIU.Lt::

wJ.:ueJ.Y

u~t:!U

.u~cc.use

it permits discrimination of the individual precipitin reactions between antibodies a.nd components of the antigen

mixture.

Counterimrnunoelectrophoresis (eIE) (36) is more

sensitive than double diffusion as well as more rapid, and
has been recommended as a routine test for Candida antibody

detection (37).

Crossed immunoelectrophoresis has been

used to detect and characterize anti-candida antibodies,
providing detailed analyses of the types of precipitins
present in patients' sera (38).

Immunofluorescence tech-

niques have also been tried, using whole Candida either in
the blastospore form (39) or the germ tube form (40), or
using Candida polysaccharide antigens engulfed by mouse
peritoneal rnacrophages (41).

Many investigators consider

elevated or rising titers of irroounofluorescent antibody
more reliable for systernic candidiasis than high or rising
agglutinin ti ters or tlle appearance of Candida precipi tins
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(3,42) .

Finally, the most recent technique suggested for detection and quantitation of anti-candida antibodies has
been enzymoimmunoassay (ELISA). (43).

The results have

been found to correlate well with immunofluorescence antibody titers and ELISA has an advantage in the ease with
which numbers of samples can be run.
The wide

vari~ty

of methods applied to the detection

of anti-candida antibodies is indicative of the problems
that remain with the serological diagnosis of candidiasis.
Although all of the above-mentioned methods are capable of
detecting antibodies, none has achieved a satisfactory degree of specificity, particularly when the differential
diagnosis between invasive systemic infection and superficial colonization is the main objective of serological
studies.

The commensal nature of the organism means that

many normal individuals may have antibodies to Candida and
many patients with superficial infections demonstrate quite
high levels of circulating antibody.

In addition, infec-

tion with fungi of several different genera may cause production of antibodies which cross-react with Candida albicans (44).

On the other hand, patients who have systemic

candidiasis may not show antibodies due to irnm.unosuppressian or rapid progression to death.
Two general approaches have been tried in an effort to
overcome the poor specificity of the currently used techniques of detection of anti-candida antibodies.

One in-
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volves quantitation of antibody concentration and is based
on the premise that higher titers of antibody may be associated with systemic disease, whereas lower titers are
found in

superficia~ly

population (45).

infected patients and in the normal

Furthermore, serial samples containing

increasing titers might indicate progressive disease, while
falling titers might occur with treatment and resolution of
the infection.
The second approach involves the refinement of crude
extracts presently used as antigens in Candida serology in

an attempt to produce a preparation that. would react specifically with antibodies found in patients with systemic
disease. It has been claimed that antibodies to cytoplasmic antigen occur only in systemic candidiasis, whereas
antibodies in normal individuals, being the result of superficial colonization, are directed to the mannan of the
cell wal·! (46).

Also, it has been shown that the cross-

reacting antibodies between other fungi and Candida are
directed to the capsular mannan (44).

In spite of this,

most of the antigens in use at present ar'e crude mixtures
containing proteins and polysaccharides, derived from sonically or mechanically disrupted Candida cells (45).
example/ the

liS

For

antigen U used by Taschdjian and colleagues,'

obtained by ultrasonication of

c.

albicans, has been shown

to contain cell wall material (45).
In addition, it has been postulated that specificity

for systemic Candida infection could be improved by using
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antigens from the mycelial phase.

As a commensal, Candida

exists primarily as yeast, but when causing an infection
the mycelial phase predominates (45).
tion from both forms is

presen~

Antigenic stimula-

in both situations, but

there should be a quantitative difference in the antibody
response.

At the present time, most of the antigens used

in serological testing for Candida antibodies are prepared
from blastospores, but the use of mycelial antigens for
routine diagnostic testing in patients with suspected systemic candidiasis may give more reliable results than are
presently obtained with yeast cell. antigens (47).
Another approach to improving the rate of successful
antemortem diagnosis of systemic candidiasis is through the
serological detection of Candida antigens in patients' sera.
This would be particularly helpful in patients who are immunosuppressed to such an extent that they are unable to
produce antibodies to the infecting organisms.

In addi-

tion, it is assumed that antigen would be present in patiel1ts

r

sera before the immunologically compete-nt patient

has been able to mount an antibody response, and thus, detection of antigenemia would allow earlier diagnosis and
earlier treatment.

Antigen detection techniques have con-

tributed greatly to the rapid, accurate diagnosis of other
fungal and bacterial infections such as Cryptococcal (48)
and bacterial meningitis (49), and so it has been seen as a
promising approach in the search for a method of diagnosing
systemic candidiasis.
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Axelsen and Kirkpatrick (50), using crossed immunoelectrophoresis, detected precipitin lines in gel containing
sera from a systemic' candidiasis patient and antibodies to
Candida antigen.

There was a reaction of identity with

lines in a standard antigen mixture.

Weiner and Yount (51)

developed a hemagglutination inhibition assay to detect
Candida surface antigen, mannan.

This assay detected anti-

gen in 30% of patients with invasive candidiasis and in no
patients with non-invasive Candida or other systemic infections.

Kerkering et al. (52) used eIE and detected poly-

saccharide antigen in 13 of 48 patients with cultures positive for Candida, 8 of whom were later proven to have systemic candidiasis.
less than 30%.

The sensitivity in this series remained

Other investigators have improved the sen-

sitivity of mannan antigen detection to approach 50% of patients with systemic disease using radioimmunoassay (RIA)
(53) and ELISA (54).

An RIA developed by stevens et al.

(21) detects soluble cytoplasmic antigen rather than mannan
and is said to be positive in approximately 65% of patients

with documented disseminated disease.

On the other hand,

Lehman and Reiss (55) developed antigen detection techniques using immunodiffusion, ClE, and ELISA and were unable to find mannan antigen in any of the human samples they'
tested including six with proven invasive candidiasis or in

the serum of heavily infected and immunosuppressed rabbits.
Jones (56) also has questioned the ability of these assays
to detect antigen in a significant percentage of patients
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with systemic disease.
One postulated reason for the difficulty ln detecting
circulating Candida antigen in the sera of infected patients is that the antigen may. be bound to antibody in the

form of circulating immune complexes.

Axelsen and Kirk-

patrick (50) noted an unusual amount of background staining
in the gel of their crossed immunoelectrophoresis and pos-

tUlated that it might be due to high molecular weight antigen-antibody complexes that did not migrate.

Several au-

thors who report success in detecting circulating antigen
have found it necessary to treat the sera before testing in
a manner that would release antigen from antibody.

Segal

et al. (57) treated the sera with 0.5 N NaOH while Weiner
and coats-Stephen (53) used acidification with 0.04 M citrate, pH 2.7 and heat treatment.
The presence of circulating immune complexes in other
fungal diseases has been suggested.

Geha (58) reported C1q

precipitins in the serum of a 13 year old child during
acute bronchopulmonary aspergillosis, but the presence of
Aspergillus antigen in the complexes was not established.
Bullock et al. (59) reported immune complexes in the serum
of a patient with disseminated histoplasmosis but again the
specific antigen was not demonstrated in the complexes.
Yoshinoya et al. (60), studying coccidioidomycosis, not only
demonstrated the existence of the circulating immune complexes but also found them to be composed of coccidioidin
antigen and specific antibody.

These studies provide sup-

1B

port for the idea that antigen circulating

i11

patients wi th

systemic candidiasis might be bound to specific antibody.

Our approach to the diagnosis of systemic candidiasis
included investigation into al.l three phases of the immune
response - circulating antigen, immune complexes, and circulating antibody.

We began with attempts to develop a

more reliable method of diagnosis using antibody detection.

Our first approach was to use quantitative immunofluorescence to achieve an estimate of antibody concentration and
to determine if higher titers are indeed associated with

systemic disease \iliereas lower titers are found in superficial infection.

Our second approach involved the study of

the effect of the type of antigen used to detect antibody,
be it cytoplasmic protein or cell wall polysaccharide and
be it from the yeast or mycelial phase of growth.
We also attempted a number of methods to detect circulating free

~andida

antigen both in the sera of patients

and in the sera of rabbits with experimentally induced Candida endocarditis.
The model for experimental Candida endocarditis was

developed by Freedman and Johnson (61) following the establis11ment of a technique for induction of staphylococcal endocarditis in rabbits (62,63).

AI-Docry et al. (64) stud- ·

ied the pathologic changes resulting from induced left-sided fungal endocarditis and found the model to closely resemble endocarditis in man.

A number of other investiga-

tors (56,65,66) have used the model to study the pathogene-
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sis of candidiasis, and we have used it as a source of materials on which to base development of antigen detection
methods.

Our lack of success with these methods led us to investigate the possibility that the antigen might be bound
to antibody and thus, that circulating immune complexes
containing Candida antigen and specific antibody might be
found in sera.

We thus performed screening tests for cir-

culating immune complexes on a number of patients with candidiasis and attempted to isolate and characterize the complexes found in some of them.

Materials and Methods

I.

Patients and Normal donors

In the development of the quantitative immunofluorescence assay, serum samples from nine patients suspected

of having systemic candidiasis on the basis of suggestive

clinical features and positive blood cultures of

c.

albi-

cans were used along with samples from 43 normal donors
with no clinical symptoms of Candida infection.

The

normal donors were divided into two groups, according to
the presence or absence of precipitating anti-candida
antibodies in their sera.

In the studies using purified antigens, two
different series of patients were used.

Fifty-seven sera

were included in series I and categorized as follows:
Group I consisted of 17 sera obtain,ed from patients who

had positive cultures for Candida species from non-cutaneous
sites.

These were divided into Group la, including nine

patients with clinical evidence of systemic candidiasis
and positive reaction when tested against a crude extract

of c. albicans yeast by double immunodiffusion , and Group
Ib, including eight patients with no clinical evidence of

systemic candidiasis and negative reaction in the double
immunodiffusion test.

Group II consisted of ten sera known
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to contain antibodies against Histoplasma and Cryptococcus.
Group III was made up of sera from 30 healthy individuals
without any sign of disease.
the persons in this group

It is probable that some of

suff~red

from subclinical mucosal

candidiasis, since this condition is relatively frequent.
Series II consisted of 44 patients with various
forms of candidiasis and ten normal controls.

In this

series, we established strict criteria for a diagnosis of
disseminated candidiasis:

1) two or more positive blood

cultures for Candida obtained on different samplings with
at least one positive in the absence of or after removal
of any potential intravenous catheter source; (2) evidence
of Candida endophthalmitis, with or without positive blood
cultures; 3) positive culture for Candida from cerebrospinal,
pleural, or peritoneal fluid; 4) positive culture of
peritoneal fluid in the absence of recent abdominal surgery,
or positive peritoneal fluid and blood cultures in the
presence of recent abdominal surgery; 5) histologic or
culture evidence of Candida at multiple tissue sites other
than normal skin and mucous rnembranes.

All of the patients

in Groups I and II of Series II fit one or more of the
cri teria described abo\Te.

The seven patients in Group I had

candidemia with multiple positive cultures and definite evidence of a deep focus of infection leading to a proven diagnosis of systemic candidiasis.

Group II consisted of five

patients with candidemia with multiple positive cultures
and clinical evidence leading to a probable diagnosis of
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systemic candidiasis.

Group III consisted of three patients

with clinical evidence of systemic candidiasis but negative
blood cultures.

Group IV consisted of three patients with

bladder or other non-invasive local infections.

These

patients had: 1) histologic or culture evidence of Candida
at a single tissue site other than normal skin or mucous
membranes; 2)

~

100,000 colonies of Candida isolated from

the urine as the sole organism on at least two different
occasions with associated pyuria

(~

10 WBC/HPF on spun

urine).
Group V consisted of 17 patients with vaginal
candidiasis.

These patients met three criteria:

1) sympto-

matic vaginitis (burning, itching, and/or leukorrhea); 2)
characteristic findings of vaginitis on pelvic examination;
and 3) the finding of budding yeast with pseudohyphae on
microscopic examination of 20% KOB wet preparations of
high vaginal secretions or plaque scrapings.

All patients

who were cultured had growth of C. albicans from the
secretions.
Group VI consisted of nine patients with cutaneous
or mucosal candidiasis who had Candida isolated from the
normal skin, stool, or mouth.

II.

Animal studies
Production of Candida endocarditis in rabbits
Endocarditis caused by Candida albicans was

induced in New Zealand white rabbits weighing 2 kg accord-
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ing to the method of Sande et ale (66).

The right carotid

artery was exposed and ligated and a sterile 19 gauge polyethylene catheter was inserted across the aortic valve.
The catheter was then clamped and the skin was closed over
it.

Candida infection was established by the intravenous
injection 48 hours later of 10 6 Candida cells. The organ-

isms had been grown on Sabouraud's dextrose agar for 48
hours and washed from the slants with sterile saline.

Af-

ter three washes with sterile saline, the cells were
counted in a hemocytometer and adjusted to a concentration
of 2 x lOG/mI.

0.5 ml was injected into the margi.nal ear

vein of each rabbit.

As controls, some rabbits were

catheterized but not infected while others were infected
without previous catheterization.

Collection of specimens
Rabbits were bled prior to infection and at
frequent intervals after infection, generally four times
during the first week and twice each week thereafter.
Sera was collected and stored at

-20~C,

and at eac}-:.. bleed

a blood culture was done by innoculating 1 ml of blood

into 10 ml of sterile brain heart infusion agar.
cultures were incubated at

37~C

The

with constant gentle

agitation and subcultured at one day and at one week.
At the time of death from disease or af.ter
sacrifice approximately four weeks post-infection, the
animals were autopsied.

Tissue samples were taken from

heart, kidney, and other organs with gross signs of infec-
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tion for cuI t'ure and for pathologic studies.

The tissue

for culture was p1.acea. ~nt.o st.er1.l.e D01=.\:).es 01:. 'nLo.~"Il 'rl~a.i."-.
infusioIl agar and treated as were the blood cultures.

The

tissue for pathologic studies was formalin fixed, embedded
in paraffin, sectioned and stained with PAS.
Sera were tested for antibody and antigen
by coun-terimrnunoelectrophoresis and by quanti tati ve immuno-

fluorescence.

III. Antibody Detection

MeL~ods

Immunodiffusion
Ouchterlony double immunodiffusion (67) was
carried out in 1% Difco (Detroit, Mich.) Noble agar prepared with 0.3 M phosphate buffer, pH 8.0 (68).

Counterimmunoelectrophoresis (CIE)
eIE studies were carried out on 8 by 5 em
glass plates coated with 8 ml of 1% LSA agarose (Litex,
Accurate Chemical and Scientific Corp., Westbury, };. Y.-)

prepared in 0.5 M barbital buffer, pH 8.6, containing 1%
(w/v) dextran T70 (Pharmacia Fine Chemicals, Uppsala,
Sweden).

The antigen and antibody wells had a diameter of

3 nun, an.d their closer edges ,,"'ere 4 rom apart.

was filled with 10

~l

Each well

of either antigen or antibody.

The

electrophoretic separation was carried out at 150 V for 90
minutes.

After completion of the run, the plates were

read on a dark field illuminator, washed twice in saline,
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once in distilled water, dried, and stained with amido
black.

The readings were repeated after staining.

Quantitative immunofluorescence (QIF)
Uncoated IDT stiQs were obtained from International Diagnostic Technology (Santa Clara, California).

These stiQs consist of a plastic handle with an immunoabsorbent disc affixed to a rounded tip which can be inserted
into tubes containing test solutions and later into the
fluorometer.

The lDT stiQs were spotted with 25

~l

of

antigen and allowed to dry at room temperature overnight.
After drying, the stiQs were washed in 600

~l

of Tris-buf-

fered saline, pH 8.1, 'containing 0.2% Tween 20, for 30
minutes at ,room temperature with constant shaking.
this wash,

L~e

After

stiQs were again dried at room temperature

and used iwnediately or stored in a sealed box at

4~C

until

needed.
The protocol for determination of antiCandida antibodies in serum samples was as follows:

(a)

serum was diluted in Tris-buffered saline, pH 8.1; (b)
stiQs were incubated wi tll 600 IJ 1 of each serum dilution for

30 minutes at room temperature, with constant gentle shaking; (c) after the incubation, the stiQs were washed for
10 minutes in 600 IJI Tris-buffered saline at room tempera-

ture with constant shaking; (d) after the wash, the stiQs
were incubated with 600

~l

of fluorescein-labeled antiserum

to human irnmunoglobulins (Burroughs-Wellcome, Research
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Triangle Park, Durham, N. C.), with constant shaking at

room temperature, and (e) this was followed by a 10 minute
wash in 600

~l

of Tris-buffered saline as described above.

After the last wash, the stiQs were read in the fluorometer.

As a control for specificity of staining, antigen-coated

stiQs were incubated with 600

~l

of Tris-buffered saline

instead of human serum and processed in an identical fashion.
When determination of antibody class was the
aim of the assay, monospecific antiserum to human IgG or
IgA (Burroughs-Wellcome, Research Triangle Park, Durham, N.
C.) was used in the final incubation step.

To assure that

tIle monospecific al1tisera to human IgG and IgA were of

comparable antibody titers, stiQ samplers were coated with
25

~l

of 10

~g/ml

solutions of purified IgG or 19A and were

incubated in 1/100 dilutions of monospecific antisera.
Means of readings on the fluorometer of six stiQs with each
a11tigen were compared using the Student's t-test alld no
significant difference was found at the level of p < 0.05.
The FlAX fluorometer (International Diagnos-

tic Technology, Santa Clara, Calif.) is a computerized instrument that allows quantitative readings of fluorescence.
Light from a highly stabilized tungsten filament source passes through a narrow band interference filter whose optical
passband is centered at 540 run, which passes only the
fluorescent signal produced by the sample.
cused

011to

Light is fo-

the photocathode of a photomultiplier tube, which
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converts the sample signals to electrical signals.

The

electrical signals are converted to a three-digit reading
and displayed on a digital panel.

Indirect Immunofluorescence (IIF)
Candida albicans type A strain B385 were
cultured in brain heart infusion agar (Difco Laboratories,
Detroit, Mich.) pH 7.4, at 25°C (69) for 48 hours, then
killed by the addition of formalin to a final concentration
of 0.5%.

Cells were harvested by centrifugation, washed

with formalinized saline, and finally suspended at 1.6 x

l06/ml in phosphate-buffered saline, pH 7.4.

One drop of

this suspension was used to make a smear which was air-dried
and heat-fixed.
slide-.
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~l

A 1 em diameter circle was marked on each

of serum diluted 1:5 in PBS was placed over

the cells in the circle and the slide was allowed to stand

in a moist chamber for

30 minutes at room temperature.

Slides were rinsed with three changes of PBS for five minutes

each.

One drop of fluorescein-labeled anti-human :gG or

IgA, diluted 1:20 in PBS was placed over the cells within
the circle and allowed to stand in a moist chamber for 30
minutes.

Slides were washed as before, mounted in buffered

glycerol, and viewed under a Leitz fluorescent microscope.

IV.

Preparation of antigens for use in antibody detection
Antigen for

i~~unodiffusion

Whole cell preparations were made according
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to Sweet and Kaufman (70).

Cells were mechanically disrup-

ted in a hydraulic press and centrifuged at 10,000 x 9 for
30 minutes.

The final supernatant fluid, concentrated and

adjusted to 5 mg/ml protein concentration, was used as the
antigen in immunodiffusion studies.

Antigens for

erE

and QIF

A commercially prepared extract of Candida
albicans, preserved in 50% glycerol, was obtained from
Hollister stier (Division of cutter Laboratories, Berkeley,
Calif.).

For use in ClE, the antigen was diluted 1:50 in

0.15 M phosphate-buffered saline, pH 7.2.

For use in QIF

the antigen was dialyzed against three changes of 0.05 M
Tris-buffered saline, pH 8.1.

The protein concentration

of the dialyzed antigen was determined by the Bio-Rad
protein assay method (Bio-Rad Laboratories, Richmand,
Calif.), and, if needed, the protein was concentrated by
negative pressure ultrafiltration.

In the development of

the QlF assay, the antigen was used at two concentlations,
0.15 mg/ml and 0.35 mg/ml.

Later, the standard concentra-

tion used was 0.15 mg/ml.
Purified mycelial antigens were prepared as
follows.

A culture of

c.

albicans type A B385 was main-

tained on Sabouraud's dextrose agar (Difco Laboratories,
Detroit, Mich.).

Cells from this stock culture were inoc-

ulated into 100 ml of the amino acid containing medium
formulated by Lee et al.

(71) in a 250 ml Ehrlenmeyer
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flask and rotated at 200 rpm at 15°C.

When this initial

culture reached stationary phase, at a blastospore concentration of approximately 2 x loB/mI, the culture was
diluted 1:15 in fresh medium (pH 6.5), bringing the total
volume to two liters, and then incubated at

37~C

in a

rotating incubator (200 rpm) to induce transition to the
mycelial phase (72).

The culture was harvested by centrifu-

gation (3000 x g) and washed three times with phosphate-buffered saline, pH 7.2.

The washed cells were disrupted by

three passages through a French pressure cell (American
Instrument Company, Silver Springs, Maryland), frozen at
-20~C,

sonicated, and passed by pressure two more times,

resulting in complete destruction of the cells (73).

The

resulting homogenate was centrifuged in three stages at
4~C

- 10,000 x g for 20 minutes, 45,000 x 9 for 30 minutes,

and 100,000 x 9 for one hour - to produce a clear supernatant (74).
The crude extract was concentrated and dialyzed for 24 hours against several changes of buffer consisting of 0.01 M Tris amino-methane-buffered saline, pH

"
7.2, contalnlng
10 -3 M caC1

)
and 10 -3 M MnCl 2 (73.
After
2
filtration through a 0.45 ~m polycarbonate membrane (Nucle-

pore, Pleasantown, Calif.), 12 ml of the crude extract was
applied to a Sepharose-ConA (Pharmacia Fine Chemicals,
Uppsala, Sweden) (25 ml bed volume) column.

This column

had previously been equilibrated with the same buffer.

Chromatography was carried out at room temperature.
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Unbound material was eluted with the equilibrating buffer.
The material bound to the ConA was eluted with 0.2 M
methyl mannoside in water (74).

The bound and unbound

fractions were concentrated and dialyzed against phosphatebuffered saline

l

pH 7.2.

The total protein concentration

and carbohydrate concentration were determined in both
fractions.

The unbound fraction is hereafter called

mycelial cytoplasmic antigen; the bound fraction, mycelial
polysaccharide antigen.
Purified yeast antigens were prepared as follows.
Cells from the stock culture of c .. albicans A B385 were
streaked onto slants of Sabouraud's agar and incubated for
18 hours at room temperature.

After microscopic determina-

tion that the organisms were growing in the yeast phase,
they were washed from the slants into 300 ml of brain
heart infusion agar in 500 ml bottles and rotated for 48
hours at 25°C (75).

1.5 ml of formalin was added to each

bottle and incubation continued at 25°C for six hours.
Cultures were harvested by centrifugation at 3000 x 9 and
washed three times with 0.5% formalinized saline.

The

final pellet was suspended at 25% (v/v) in formalinized
saline.

Purification was continued as for mycelial cells

resulting in a yeast cytoplasmic antigen preparation and a

yeast polysaccharide antigen preparation.
An aliquot of. the Hollister-stier extract

of Can.dida albicans was also purif.ied.

Fifteen ml of the

extract was dialyzed for 72 hours against daily changes of
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distilled water.

The antigen was concentrated and treated

in the same fashion as the crude mycelial extract and then
chromatographed on a Sepbarose-ConA column.
The protein concentration in the various antigenic
preparations was determined by the Coomasie blue dye-bind-

ing technique (76) (Bio-Rad Laboratories, Richmond, Calif.),
using bovine gamma globulin as a calibration. standard.
The phenol-sulfuric acid colorimetric method was used for
total carbohydrate analysis (77).

A standard curve based

on a mixture of sugars was used for the guantitation of
the carb0hydrate.
For eIE the cytoplasmic antigen preparations
were used at a protein concentration of 1 mg/ml and the
polysaccharide antigen at a carbohydrate concentration of
170

~g/ml.

For QIF the cytoplasmic antigen was used at a

protein concentration of 0.25 mg/ml and the polysaccharide
~g/ml.

antigen at a carbohydrate concentration of 90

v.

Carbohydrate Analysis of C. albicans antigens
Carbohydrates in the antigen preparations were

further analyzed by gas-liquid chromatography.
of each preparation, adjusted to contain 100

~g

An aliquot

of sugar,

was dried under a stream of nitrogen, then heated for 16

hours at

65~e

with 1 ml of 500 roM HCl in anhydrous methanol.

The samples were again dried under a stream o£ nitrogen,
and N-acetylation of the free amino groups was achieved by

suspending the residue in a mixture of 0.1 ml acetic anby-
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dride.

The samples were immediately evaporated to dryness

and the simultaneous a-acetylation was reversed by refluxing in 1 ml of 500 roM Hel diluted in anhydrous methanol

for one hour (78).
The constituent carbohydrates were converted to

o-trimethyl-silyl ethers (o-TMS ethers) by treatment with
Tri-Sil (Pierce Chemical Co., Rockford, Ill.) for 15 minutes at

65~C

(79).

The samples were then dried, and the

o-TMS ethers dissolved in 0.5 ml hexane solution were
injected into a varian 4000 dual column gas-liquid chromatograph fitted with an aV-17 column.
was

90~C

The initial temperature

with a 1 minute hold, increasing

10~

per minute

thereafter until reaching an upper limit of 250°C.
temperature was held for 10 minutes.

This

Nitrogen was used as

a carrier gas, at a flow rate of 37.5 ml/roinute.

The

separations were calibrated with o-TMS ethers of mannose
and glucose.

VI.

Antigen Detection Methods
Counterimmunoelectrophoresis

eIE studies for antigen detection were carried out as were those for antibody detection.
Two different types of antibody were used
to detect antigen.

A commercial preparation of rabbit

immunoglobulins to Candida albicans was obtained from
DAKO-irr~unoglobulins

(Copenhagen, Demnark).

The antisera

was further purified by chromatography on a DEAE-Sephacel
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column (Pharmacia Fine Chemicals, Uppsala, Sweden) equilibrated with 0.01 M Tris-HCl, pH 7.0 (80).

The column was

eluted with 0.05 M Tris-HCl, pH 7.0 to obtain Peak I and
then with the same buffer containing 0.25 M NaCl to obtain
a second peak.

A

final wash was done with 0.05 M Tris-HCl,

pH 7.0 with 1 M NaCl.

The peaks were concentrated by

ultrafiltration and checked for antibody activity by eIE
and for immunoglobulin purity by immunoelectrophoresis
Protein concentration was determined by the Bio-Rad

(81).

protein assay method.

CIE showed

t~at

the maj,ority of the

antibody activity was in Peak If and IEP showed that Peak
I was pure IgG.
Antibody was also obtained from the sera of two patients (VL and LS) with a high titer of anti-candida antibodies.

These sera also were applied to DEAE-Sephacel

equilibrated with 0.01 M Tris-HCl, pH 7.0, and the peak
containing pure IgG with maximal antibody activity was
eluted with the equilibrating buffer.
The limits of antigen detection by l-oth the
purified commercial rabbit immunoglobulin and the purified
human antisera were determined by CIE.

The rabbit antibody

at 1 mg/ml detected 500 ng/ml of Candida antigen.

The an-

tibody purified from VL sera at a concentration of 0.5 mg/
ml detected 200 ng/ml of antigen.

The antibody purified

from LS sera at a concentration of 2 mgjml detected 200
ngj ml of antigen.
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Quantitative Immunofluorescence Inhibition Assay
Uncoated IDT stiQs were spotted with 25

~l

of Candida antigen, a yeast extract with a protein concentration of 50
~g/ml.

~g/ml

and a carbohydrate concentration of 50

After being allowed to dry at room temperature
~l

overnight, the stiQs were washed in 600

of the assay

buffer, Tris-buffered saline, pH 8.1 containing 0.2% Tween
20.

In the assay, stiQs were incubated for 30 minutes in

600 ~l of one of the following:

rabbit anti-candida immu-

noglobulins (DAKO) diluted 1:200 in assay buffer as the
100% positive control; a preincubated mixture of equal volumes of rabbit anti-candida diluted 1:100 and various concentrations of Candida antigen to establish a standard
curve; a preincubated mixture of equal volumes of rabbit
anti-candida 1:100 and sera to be tested.
incubation, the stiQs were washed in 600

Following this
~l

of assay buffer

for 10 minutes at room temperature with constant shaking.
Then, stiQs were incubated with 600

~l

of fluorescein-la-

beled sheep anti-rabbit inununoglobulins (Burroughs-Wellcome, Research Triangle Park, Durham, N. C'.) diluted 1:100
in assay buffer for 30 minutes at room temperature.

After

a final ten minute wash in assay buffer, the stiQs were
read in the FlAX fluorometer.

ELISA Inhibition Assay
A modification of the method of Segal et
al.

(57) was used.

Cuvettes supplied as the solid phase
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for the Gilford ErA Automatic Analyzer System PR-50 (Gilford Instrument Laboratories, Inc./ Oberlin, Ohio) were
coated with Candida yeast extract antigen.
antigen diluted to a concentration of 2

100

~g/ml

~l

of the

in 0.1 M

carbonate buffer, pH 9.6 was incubated in each test well
of the cuvette overnight at

4~C.

control wells were

incubated with carbonate buffer without antigen.

After

this incubation, the cuvettes were washed four times on
the processor of the Gilford EIA automatic analyzer, using
as assay buffer, 0.15 M phosphate-buffered saline, pH 7.2
containing 0.05% Tween 20.
one of the

~ollowing

incubated at

37~C

In the next step, 100

~l

0f

was added to a cuvette well and

for 30 minutes:

PBS with Tween 20 as a

control; rabbit anti-candida antibodies (DAKO) diluted
1:1000 in the assay buffer as the 100% positive sample; a
preincubated mixture of equal parts of rabbit anti-candida
diluted 1:500 and Candida antigen at various concentrations
to establish a standard curve; or a preincubated mixture
of equal parts of rabbit anti-candida immunoglobulins
1:500 and sera to be tested.

After this incubation, the

cuvettes were washed seven times with the assay buffer.
Then, 100

~l

of horseradish peroxidase-labeled swine

anti-rabbit IgG (Cappel Laboratories, Downington, Pa.)
diluted 1:1000 in assay buffer was added to each well for
a one hour incubation at

37~C.

Again, the cuvettes were

washed seven times with the assay buffer.

Then, 200

~l

of

freshly made working substrate solution was added to each
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well.

The working substrate solution consisted of

1%

stock substrate and 0.3% hydrogen peroxide (Eckerd Corporation, Clearwater, Fla.) in 0.05 M citrate phosphate buffer,
pH 5.0.

The stock substrate was made up weekly as 0.001%

orthophenylenediamine (sigma Chemical Company,
Mo.) in methanol.

st. Louis,

After a 45 minute incubation in the

dark at room temperature, 200

~l

of 4 N sulfuric acid was

added to each well to stop the reaction.

The color reaction

was read by the spectrophotometer incorporated into the
Gilford system at a wavelength of 490, and the measured
absorbance value with a range of o.to 2.0 was printed out
by a thermal printer.

Sera to be tested in both types of inhibition assay were used either untreated or treated by the
method of Segal et al. (57) to remove any bound anti-candida
antibodies.

In this method, one volume of 3 N NaOH was

added to 5 volumes of sera and the mixture was incubated
for 2 hours at

56~C.

After centrifugation at 2000 x 9 for

5 minutes, the supernatant was dialyzed against PBS before
testing in the assay.

VII. Immune Complex Studies
Immune Complex Screening Techniques
Direct nephelometry
A modification of the method previously
described by Virella et al. (82) was used.

The method

consists of determining the effects of polyethylene glycol
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6000 (Fisher, Fairlawn, N. J.) on the immune complexes in
the sample, assuming that an increase in light scattering
reflects the specific aggregation of soluble immune complexes.

Light scattering is measured in a Hyland PDQ Neph-

elometer (Hyland Diagnostics, Deerfield, Ill.), with the
sensitivity set at 3 and 7 (course and fine) and a final
adjustment to obtain a reading of 170 to 190 using a reference latex suspension (0.010 ml of a suspension of polystyrene latex particles, 0.035

~m

in diameter (Dow Diagnos-

tics, Indianapolis, Ind.) in 10 ml of 3% (w/v) polyethylene
glycol 6000 solution in 154 roM NaCl.

The sample values

are recorded as a percentage of the latex suspension reading, after the sample blank values have been obtained.

PEG-IgG and PEG-C 4 Tests

These are modifications of the origindl
procedures of Digeon et ale (83).
are incubated overnight at

4~C

The samples to be tested

with 3% (wjv) polyethylene

glycol 6000 to 0.01 M borate-buffered saline, pH

8~4.

The

resulting precipitates are washed twice in 3% polyethylene
glycol 6000 at 4°C and resuspended in 0.4% Tween 20 in

borate buffer and incubated at

37~C

f.or 30 minutes.

The

IgG and C4 are assayed nephelometrically in both the original serum and the resuspended precipitates. The results
are expressed as a ratio between IgG or C4 in the precipitate and the corresponding value in the serum.
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125 1 C1q Binding Assay
A modification of the method of Zubler
and Lambert (84) was used.

c1q was isolated by the method

of Volanakis and Stroud (85) and labeled by the method of
McConahey and Dixon (86).

Purity was determined by double

immunodiffusion and immunoelectrophoresis.

Biological ac-

tivity was assessed by measuring the ability of the c1q to
agglutinate IgG-coated latex (Rbeuma-Wellcotest, Wellcome
Diagnostics Research Triangle Park, Durham, N. C.).

The

results of the binding assay were expressed as:

%C1q binding = sam¥le value x 100
x 0
controls

Ie score
The results of the immune complex
screenlng tests were used individually and were compiled by
the method of Kilpatrick and Virella (87) into an Ie score.
This score was derived in the following manner:

the mean

value of the normal control population for a given test was
subtracted from the value for a given sample in the same
assay, and the resulting difference was divided by the
standard deviation of the values obtained with the normal
control.

The mean of the corrected scores for the differ-·

ent assays was then recorded as the Ie score.

Isolation of Soluble Immune Complexes
The method described by Virella et al.
(88) was employed for the isolation of soluble immune complexes.

Briefly, 1 ml of 20% polyethylene glycol 6000 in
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borate buffer was added slowly to 3 ml of serum to be examined.

The mixture was allowed to stand at room tempera-

ture for one hour and at

4~C

for two hours.

This mixture

was then centrifuged at 35,000 x 9 for 30 minutes and the
precipitate was suspended in 500 roM potassium phosphate
buffer, pH 7.5 and dialyzed against three changes of 0.1 M
phosphate-buffered saline, pH 7.3.

The sample was applied

to a 5.5 by 34 em column of ACA -34 (LKB Instruments, Inc.,
Rockville, Maryland) equilibrated with PBS for separation
of fractions by molecular weight.

The higher molecular

weight frac,tions were pooled and concentrated by negative
pressure ultrafiltration and applied to a 1.5 by 10 em
column of Sepharose 4B - Protein A (Pharmacia Fine Chemicals/ Uppsala, Sweden).

The column was eluted with PBS

with the elution monitored at 280 nm.

After the elution

of the unbound protein, when the eluate had an optical density near 0, 0.2 M acetate buffer, pH 3.8 was used to
elute the bound immune complexes.
For the final dissociation of antigen and
antibody, the protein eluted with the acid buffer from the
protein A affinity chromatography column was submitted to
a final fractionation at pH 3.8 on a 1.5 by 60 em column of
ACA-34.

Characterization of Isolated Immune Complexes
Immunochemical characterization of the proteins separated at different stages of the isolation proto-
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col were carried out uSlng double immunodiffusion, performed in 1% Difco Noble agar in 0.02 M potassium phosphate
buffer, pH 8.0.
follows:

Anti-sera used in these studies was as

goat anti-human IgG heavy chain (Antibodies, Inc.,

Davis, Calif.);

sh~ep

anti-human IgM, heavy chain specific

(Cappel Laboratories, Cochranville, Fa.); goat anti-human
IgA, heavy chain specific (Cappel Laboratories); goat antihuman c1q (Atlantic Antibodies, Scarborough, Maine); goat
anti-human C3 (Cappel Laboratories); and goat anti-human C4
(Atlantic Antibodies).
Fractions from different stages of the isolation procedure were tested for the presence. of anti-candida antibodies by counter immunoelectrophoresis and by
quantitative immunofluorescence.

Candida antigen was de-

tected by counterimrnunoelectrophoresis and by the quantitative immunofluorescence inhibition assay.

YIII.statistical Analysis
statistical analysis of the distribution of antibody levels as determined by quantitative immunofluorescence indicated skewness not consistent with a normal dis-

tribution of values.

Therefore, comparison of antibody

levels in patient and normal groups was accomplished using
non-parametric techniques.

wilcoxon's two sample test as

extended by Mann and Whi tney to deal with une'qual-sized
samples was used in the studies on antibody detection (89).
In the immune complex studies data was also anal-
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yzed by the Mann-Whitney test to determine the level of
significance of the differences between normal and patient
popUlations.

Results

I.

Development of the QIF Assay
Our attempts to improve the specificity of the

antibody detection methods of diagnosis of systemic candidiasis through quantitation of antibody concentration resulted in the development of a new assay using quantitative
immunofluorescence.

Counterimmunoelectrophoresis was used

as the reference technique in the development of the new

assay.
In our initial experiments, we determined the optimal concentrations of antigen and fluorescent antiserum
for the assay.

Commercial Hollister-stier antigen was used

at this stage of the investigation.

Two sera were used,

one strongly positive and the other negative by eIE for
anti-candida antibodies, both at a dilution of 1:20.

The

stiQs were spotted with c. albicans antigen at two different concentrations, 0.15 and 0.35 mg/ml.

The fluorescein-

labeled antiserum to human immunoglobulins was used at
three different dilutions, 1:20, 1:50 and 1:100.

The re-

sults of these experiments (Table 1) showed good differentiation between the positive and negative samples at all
combinations of antigen and antibody tested.

We observed

no fluorescent staining when antigen-spotted stiQs were in-

cubated with Tris-buffered saline instead of human serum.
In all subsequent experiments, the antigen was used at a
concentration of 0.15 mg/ml and the fluorescent antiserum
was diluted 1:100.
The objective of the next series of experiments

was to determine whether a correlation could be est.ablished

between different concentrations of a positive serum and
the readings obtained with the fluorometer, keeping the
concentrations of antigen and fluorescent-labeled antiserum
constant.

Figure 1 illustrates the correlation between the

intensity of fluorescence and the dilution of positive
serum.

The range of dilutions 1:40 to 1:1280 was chosen to

encompass the interval in which antibody· concentrations of

a majority of unknown sera fell, and to reach the lower
limit of sensitivity of the assay.

The lowest dilution of

the positive serum (1:40) was considered as 100%, and each

following dilution was expressed as a percentage of this
maximum.

The correlation obtained (Figu.re 1) permitted

calibration of the assay.
When unknowns were assayed, ea·ch sample was diluted 1:40 and the samples were run in duplicate.

The

fluorescence readings obtained in the duplicate assays were
converted into percentages of the posi t.ive c.ontrol.

The

results of our assays of an initial group of unknown samples and the results of erE assays of the same samples are
shown in Table 2.

The sera were grouped into three catego-

ries according to whether they were obtained from patients
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with clinical and cultural evidence of systemic candidiasis
(Group I) or from normal controls who were positive· (Group
II) or negative (Group III) for precipitating antibodies to
C. albicans as detected by eIE.

statistical analysis of

the groups by the Mann-Whitney test showed that antibody
levels in the Group I subjects were significantly different
from the levels of normals in Groups II and III (p < 0.01).
Similarly, significant differences

(p < 0.01)

were found in

comparisons of Groups II and III.
Finally, we tested the reproducibility of the assay by repeating the determinations of five sera.

Five

tests of each sample were run ln one experiment to determine within run reproducibility.

The same samples were. run

in duplicate on five other occasions; the results of these
repeated determinations are shown in Table 3.

II.

Use of Purified Candida Antigens

Once this quantitative assay for anti-candida
antibodies was developed, we redirected our approach to improving the serodiagnosis of Candida toward the area of refinement of antigens used to detect the antibodies.

Analysis of the Antigens
The preparation of mycelial and yeast extracts as described in Materials and Methods provides a
mixture of antigens in which proteins predominate over carbohydrates (Table 4).

Affinity chromatography on ConA-

TABLE 1
STUDY OF THE EFFECTS OF VARIATIONS IN ANTIGEN AND
FLUORESCEIN-LABELED ANTIBODY CONCENTRATIONS ON
THE INTENSITY OF FLUORESCENCE OBTAINED WITH
SERUM FROM A PATIENT WITH SYSTEMIC CANDIDIASIS AND
WITH SERUM FROM AN ASYMPTOMATIC CONTROL

Antigen at 0.15 mg/ml

Antigen at 0.35 mg/ml

Patient a

Control a

Patient a

Control a

FITC-anti-Ig 1/20

184

19

195

29

FITC-anti-Ig 1/50

200

23

200

31

FITC-anti-Ig 1/100

164

16

148

22

Antiserum

aBoth sera diluted 1/20. The fluorescence intensity measurements are
expressed in arbitrary units, as calculated by the FlAX fluorometer.

.po

v.

Figure 1

semi-log plot of fluorescence intensity vs. antibody
concentration obtained with a series of doubling dilutions
(1/40 to 1/1280) of a serum containing anti-C. albicans
precipitates at a titer of 40 by

erE.

The intensity of

fluorescence is expressed in the units given by the fluorometer readouts.

The antibody concentrations are expressed

as percentages of the lowest dilution of the positive serum
(designated as 100%).

i

100

50
" of

25
Maximum

12.5

6.25

i
3.1

47

TABLE 2

RESULTS OF QUANTITATIVE IMMUNOFLUORESCENCE AND
COUNTERIMMUNOELECTROPHORESIS DETERMINATIONS OF
ANTI-CANDIDA ANTIBODIES
Group IIb

Group I a
Case no.

QIF (%) eIE

Case no.

1
2

>100
100
31
22

+

10
11
12
13

+

14

3

4
5
6
7
8
9

Mean
±S.D.

18
12
11 . 4

8.3

5.7
26.0
±30.9

+
+
+

22.1
11.4

23
24
25
26

3.0

27
Mean
±S.D.

0

15

+

16
17

+
+

QIF (%) eIE

9.4
9.0
8.6
8.4
8.4
8.4
7.9
6.3
5.7
5.7
5.1
5.0
5.0
3.5

+

+
+

Group III c

18
19
20
21
22

7.5%
±4.5%

+
+
+

Case no.
28
29
30

+
+

31

+
+

33
34

+

+

35
36

+

37

+
+

38

+
+

40

32

39

QIF c%) eIE
8.2
7.8
6.6
4.2

4.u
3.8
3.4
3.0
3.0
2.8

2.7
1.9
1.8
0.6

+

41
42

0

+

43

0

+
+

44
45
46

0
0

47

48
49
50

51
Hean
±S.D.

0
0
0
0
0

0
2.2%

±2.6%

aGroup I, patients with systemic candidiasis
bGroup II, normals with positive precipitin test for anti-Candida antibodies.
cGroup III, normals with negative precipitin test for anti-Candida antibodies.

TABLE 3
WITHIN-RUN A1~ DAY-TO-DAY PRECISION
OF THE QUANTITATIVE IMMUNOFLUORESCENCE
ASSAY FOR ANTI-CANDIDA ANTIBODIES
Within-run (n

= 5)

Day-to-Day {n = 5)
Mean QIfOk
CV%

Mean QIF%

CV%

2.98

9.4

4.36

30.96

3.04

8.55

4.01

19.20

5.52

13.41

8.10

40.74

18.06

4.21

20.21

10.49

11.76

18.45

18.63

14.65

Mean

10.80

Mean

23.21
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Sepharose resulted in the separation of two fractions, one
containing the unabsorbed material washed out with the equilibrating buffer (Fraction I) and the other (Fraction
II) containing polysaccharides bound to the insolubilized

ConA and specifically eluted with alpha-methyl mannoside.
Chemical analysis of both fractions showed that Fraction II
was practically devoid of protein.
The commercially-prepared Hollister-stier antigen
was found to be rich in carbohydrates; fractionation by affinity chromatography on ConA-Sepharose also resulted in
the separation of two fractions I an unbound Fraction II
rich in proteins and a bound Fraction II, rich in carbohydrates.
The nature of the carbohydrates present in the
crude antigen preparations and their respective fractions
was studied by gas chromatography.

These studies allowed

the identification of glucose and mannose in all antigenic
preparations containing detectable sugar.

Representative

profiles obtained in these studies are shown in

Fi~ure

2.

Basically, these results show that mannan is present as a
contaminant in crude extracts and can be removed by affinity chromatography using Sepharose-ConA, as previously shown
by Longbottom et ale

(73).

Comparison of Reactions with the Various Antigens

Using eIE
Initial tests of sera from patients in

TABLE 4

CHEMICAL ANALYSIS OF THE CRUDE MYCELIAL AND YEAST EXTRACTS
AND OF THE HOLLISTER-STIER ANTIGEN
AND THEIR RESPECTIVE FRACTIONS OBTAINED
BY AFFINITY CHROMATOGRAPHY ON CONA-SEPHAROSE

Yeast ag

Mycelial ag
Crude

Frac

I

Protein
cone.
(mg/ml)

2

1

Carbohydrate
cone.
(mg/ml)

0.75

ND

ND -

not detectable

Frac

Crude

ND

II

0.17

Hollister-stier

Frac --FracCrude'Frac

I

F'rac

I

II

II

2.2

2.7

ND

0.3

0.1

2.65

ND

0.18

1.2

0.075 0.39

0.1
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Figure 2

Gas chromatography profiles of the fractions eluted
from ConA at neutral pH (ConA washout, Fraction I) and of
the fractions bound to ConA, requiring elution with alphamethyl mannoside (ConA bound, Fraction II) from the Hollister-stier antigen.

The separation of two control sugars

(mannose and glucose) is also shown.

The figures under

each peak represent the distances measured in the graph between the beginning of the recording and the a.ppearance of
the peak.

It can be seen that the major carboh:ydrate peaks

in the ConA-bound material correspond to mannose.
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glucose

mannose

J
.

.

Hollister-Stier extract
Con A washout

~ '. '

Hollister-Stier extract

ConA bound

53

series I were done uSlng eIE to compare reactions with the
commercial Hollister-stier extract and the purified mycelial

antigens which we theorized to be the most specific for
systemic infection based on the belief that the mycelial
phase predominates as the organism's invasiveness progres-

ses.

Table 5 shows the results of these tests.

Of 17

culture-positive patients included in Group I, 16 were
found to be positive by eIE using commercial antigen,
showing a greater sensi tivi t:i7 in this test than in double
immunodiffusion, since eight patients of Group Ib were
negative by the latter assay.

However, this high frequency

of positive results by eIE was obtained only with Fraction

II (polysaccharide antigen) of the mycelial extract.

With

the cytoplasmic antigen, seven of nine Group Ia patients
with clinical indications of systemic candidiasis, positive
cultures, arld positive results by double immunodiffusion

test were positive , and no other patient or normal control
showed reactivity.

Of the two negative Group~ Ia patients,

one was infected with a strain of

c.

tronicalis.
*

We also found that the ten patients in Group II with
antibodies to fungi other than Candida whose se'ra showed
precipitin lines when tested with Hollister-stier antigen

reacted exclusively with the polysaccharide fraction of
the mycelial extract.
normal control sera was
ride antigens of

c.

The reactivity of the 14 positive
similarl~r

directed to polysaccha-

albicans.

The fractions purified from the Hollister-stier anti-

gen were tested on a more limited scale, but with similar
results, in spite of the lesser degree of purity of these
fractions.

Of six sera tested, five were positive with the

whole Hollister-stier antigen and one negative (Table 6).
Of the positive sera, one was a normal donor, one was a patient with antibodies to Histoplasma, and three were patients with clinical evidence of systemic candidiasis and
cultures positive for Candida albicans.

All five sera were

positive when tested with Fraction II (polysaccharide antigen), whereas only the three from patients with suspected
systemic candidiasis showed reactivity with Fraction I (cytoplasmic protein).
To

complete our initial studies r selected patients'

sera were tested by CIE for antibodies to yeast cytoplasmic
and polysaccharide antigens to determine if any difference
in reactivity was present depending on the growth phase of
the organism (Table 7).

with 19 sera tested, reactions

with yeast polysaccharide were identical with
with mycelial polysaccharide.

r~actions

Three of the 19 who were

negative with yeast cytoplasmic antigen were positive with
mycelial cytoplasmic antigen.
Because of these promising initial studies, further
investigation was done on another series of patients (Series II as defined in Materials and Methods).

These pa-

tients' sera were tested by counterimmunoelectrophoresis
against the unpurified Hollister-stier antigen and against
all four of the purified antigens prepared in our lab - the

TABLE 5
RESULTS OF eIE USING DIFFERENT ANTIGENS TO TEST SERA OF PATIENTS IN SERIES I
patieRt
group

No.

positive reactions by counterimmunoelectrophoresis
Hollister-stier
antigen

Mycelial antigen
Fraction I
(cytoplasmic)

Fraction II
(polysaccharide)

Ia

9

9

7

9

Ib

8

7

0

7

II

10

10

0

10

III

30

14

0

14

a See Materials and Methods for definition of patient groups in
Series I.

V1
VI
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TABLE 6
RESU.LTS OF eIE

USING FRACTIONATED HOLLISTER-STIER ANTIGEN
Crude

Fraction I

Fraction II

1

+

+

+

2

+

+

+

3

+

+

+

4

+

+

5

+

+

Patient

6
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TABLE 7
RESULTS OF eIE STUDIES CO~WARING RESPONSES
TO YEAST AND MYCELIAL ANTIGENS
Antigens
Patient

Yeast
CytoPolysaccharide
plasmic

Mycelia
CytoPolyplasmic
saccharide

1

±

+

2

+

+

3

+

+

+

+

4

+

+

+

+

+

+

+

+

±

+

5
6

±

7

+

+

8

+

+

+

+

9

+

+

+

+

10

+

+

+

+

11

+

12

+

13

+

+

+

14

+

+

+

+

15

+

+

+

+

16

+

+

+

17

+

18
19

+
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yeast cytoplasmic and polysaccharide antigens and the
mycelial cytoplasmic and polysaccharide antigens.

Table 8

shows the results of erE tests on these patients' sera.
All of the sera from the groups with proven or probable disseminated candidiasis reacted with the unpurified
Hollister-Stier antigen but, in addition, reactions were
obtained with two of three patients with localized infection,
three of nine with vaginal candidiasis, four of nine with
mucocutaneous candidiasis, and 14 of 30 normals as had
been shown in Series I.

Reaction with the yeast and

mycelial polysaccharide antigens occurred in 11 of 12
patients in Groups

I

and II but also was seen in 14 of the

normals ·and in five of the ten in Groups III to VI who had
reacted with the u'npurified antigen.

Reaction with the

cytoplasmic antigens was much more specific.

Seven out of

seven patients with proven systemic candidiasis reacted

with the yeast cytoplasmic antigen and four out of seven
with the mycelial cytoplasmic antigen.

The three who did

not react with mycelial cytoplasmic antigen all
calis infections rather than c. albicans.

ha~

c.

tropi-

Only one patient

in any of the other groups reacted with either cytoplasmic
antigen.

That patient had a long-standing chronic mucocu-

taneous candidiasis.

An

interesting additional note is

that three of the patients with disseminated disease who
had serial samples collected had only anti-polysaccharide
antibodies when first studied but developed anti-cytoplasmic
antibodies as their disease progressed (Table 9).
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TABLE 8
RESULTS OF eIE USING DIFFERENT ANTIGENS
patien~

Group

positive reactions wlth b
me
yc
yp
mp

No.

H-S

I

7

7

7

7

4

6

II

5

5

2

4

2

5

III

3

1

0

1

0

0

IV

3

2

0

2

0

1

V

9

3

0

0

0

0

VI

9

4

0

2

1

3

a See Materials and Methods for definition of patient
groups.

b H-S = Hollister-Stier antigen; ¥c = yeast cytoplasmic
antigen; ¥p = yeast polysaccharIde antigen; me = mycelial
cytoplasmIc antigen; mp = mycelial polysaccharide antigen.
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TABLE 9

APPEARANCE OF ANTI-CYTOPLASMIC ANTIBODY IN
PATIENTS WITH SYSTEMIC CANDIDIASIS

Date

Patlent
Cyto

LM

Date

Patlent
Cyto

Poly

LS

Date

Poly

Cyto

11/4

+

5/29

+

6/5

12/19

+

6/6

+

6/11

1/6

+

6/.20

+
+

1/21

+

+

7/7

2/23

+

+

7/31

+

+

Patlent

ET

Poly
+

+

+
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Comparison of Reactions with the Various Antigens
Using QIF
Sera from 30 patients were tested by quantitative immunofluorescence f.or antibodies to all of the purified antigens, and sera from 10 healthy controls were
tested in the same way to obtain a range of normal values
(Table 10).

Patients 1-14 fit our criteria (see Materials

and Methods) for a diagnosis of systemic candidiasis.

Pa-

tients 15 - 28 had local or mucocutaneous infection and 29
and 30 were infected with other fungi.

The Mann-Whitney

test was used to analyze differences between the mean values for the systemic, local and mucocutaneous, and normal
groups (Table 11).

It can be seen (Table 10) that the mean nor-

mal antibody level to the polysaccharide antigens is higher
than that to the cytoplasmic antigens and the standard deviation is substantially larger.

This r·eflects the pres-

ence of antibodies to cell wall mannan of yeas.ts in many
normal individuals as was seen in our CIE data.

However,

statistical analysis (Table 11) of the difference between
quantitated levels of antibody in the normal group and in a
group of systemic patients showed that use of polysaccharide antigens in a quantitative technique can be quite use-'
ful in diagnosing systemic disease.

The level of signifi-

cance of the difference between the two groups with the
yeast polysaccharide antigen was p = 0.0003 and with the
mycelial polysaccharide was p < 0.0001.
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Comparison of Reactions with the Various Antigens
Using QIF
Sera from 30 patients were tested by quantitative immunofluorescence for antibodies to all of the purified antigens, and sera from 10 healthy controls were
tested in the same way to obtain a range of normal values
(Table 10).

Patients 1-14 fit our criteria (see Materials

and Methods) for a diagnosis of systemic candidiasis.

Pa-

tients 15 - 28 had local or mucocutaneous infection and 29
and 30 were infected with other fungi.

The Mann-Whitney

test was used to analyze differences between the mean values for the systemic, local and mucocutaneous, and normal
groups (Table 11).
It can be seen (Table 10) that the mean normal antibody level to the polysaccharide antigens is higher
than that to the cytoplasmic antigens and the standard de-

viation is substantially larger.

This reflects the pres-

ence of antibodies to cell wall mannan of yea.sts in many
normal individuals as was seen in our CIE data.

However,

statistical analysis (Table 11) of the differen.ce between
quantitated levels of antibody in the normal group and in a
group of systemic patients showed that use of polysaccharide antigens in a quantitative technique can be quite use-'
ful in diagnosing systemic disease.

The level of signifi-

cance of the difference between the two groups with the
yeast polysaccharide antigen was p

= 0.0003

mycelial polysaccharide was p < 0.0001.

and with the
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Looking at individual patients to see if
their quantitated antibody levels were greater than two
standard deviations above the normal mean (Table 12) shows
that the mycelial polysaccharide antigen was quite sensitive for detecting systemic disease with 13 out of 14 patients having values above the cut-off.

The one remaining

patient had a value of 25.5, very near the cut-off of

26.8.

The yeast polysaccharide antigen was a little less

sensitive, however, picking up nine out of 14 patients
with systemic disease.
Analysis of the differences between the
systemic group and the local and mucocutaneous group again
showed the polysaccharide antigen to be quite useful In
the quantitative test.

The level of significance of the

difference with yeast polysaccharide was p = 0.0004 and
with mycelial polysaccharide

wa~

p < 0.0001.

Analysis of

the difference in antibody levels between the local and
mucocutaneous group and the normals showed no significant
difference with either of the polysaccharide antigens or
with the mycelial cytoplasmic antigen,

assuming a p < 0.05

level to be necessary for significance.
statistical analysis of the differences between the levels of anti-cytoplasmic antibody in the three
groups revealed a generally less significant difference
than was found with the anti-polysaccharide antibodies,

with the exception that yeast cytoplasmic antibodies revealed the only significant difference between the local
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and mucocutaneous group and the normals.
that difference was p

= 0.0401.

The level of

The difference between

the systemic and normal groups with yeast cytoplasmic
antigen was significant at a level of p = 0.0089 as compared
with the yeast polysaccharide antigen at a level of p 0.0003.

The difference with the mycelial cytoplasmic

antigen was significant at a level of p = 0.0268 as compared
with the p < 0.0001 level found with mycelial polysaccharide.
The differences between the local and mucocutaneous group
and the systemic group were not significant at a p < 0.05
level wi t.h yeast cytoplasmic while wi th mycelial cytoplasmic
there was significance at a level of p = 0.0409.

It is

interesting that patients 12, 13, and 14 were classified
as systemics on the basis of multiple positive blood
cultures but had no proven deep focus of infection, and

these three patients had low values of anti-cytoplasmic
antibodies as compared with the majority of the patients
(#1-11) who had a proven deep focus of infection.

Patient

#11 who also had low anti-cytoplasmic antibodies hcd a

very rapid progression to death f.rom the beginning of his

disease.

Looking at Table 12, these four patients and one

other were the only five systemic patients who did not
have levels greater than two standard deviations above the
normal mean with mycelial cytoplasmic antigen.
Patients 29 and 30 who had other fungal infections and who had anti-polysaccharide antibodies by eIE
did not have antibody levels greater than two standard de-
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viations above the normal mean against any of the antigens
when tested quantitatively.

III. Use of QIE to Determine Antibody Class
The quantitative immunofluorescence assay which
had been developed by us and used to measure concentrations
of antibody to various types of Candida antigen could be
modified for other uses as well.

One which was investigated

was the determination of class of antibody, which would be
easily accomplished by changing the specificity of the
fluorescent antisera so that antibodies of only one class
would be determined.

This modification was used to test

the hypothesis that superficial forms of Candida infection
might lead to the production of antibodies of the IgA
class in higher titer than, or to the exclusion of, other
classes of antibody due to the association of IgA with
mucosal epithelium.

It was hoped that, if this were true,

it might aid in differentiation between superficial and
deep-seated infections.

Earlier studies on this question

(32, 90) had been done using an indirect immunofluorescence
test on smears of Candida albicans cells and had lead to
conflicting results.
We used our group of vaginal candidiasis patients

(see Materials and Methods for diagnostic criteria) and
tested the sera first for precipitating antibodies to the
Hollister-stier extract of c. albicans and to purified
cell wall polysaccharide since that antigen is the primary one
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TABLE 10
RESULTS OF QIF STUDIES OF RESPONSES TO CYTOPLASMIE
AND POLYSACCHARIDE ANTIGENS OF YEAST AND MYCELIA

Patient a
1

2
3
4
5
6
7
8
9

10
11
12
13
14
15
16
17
18

19

Antigens
Yeast
Mycelia
Cytoplasmic Polysaccharide Cytoplasmic Polysaccharide
7.6
9.5

~

14.6
8.1
6.4
6.4
8.3
5.8
26.8
2.5
14.8
4.8
6.4
4.8
3.8

5.1
7.6

8.3
2.2
1.0
8.3
5.1

28
45.2
22.3
16.6
49.7
28.7
17.2
12.1
15.9
96.8
25.2
16.6
117.2

27.7

13.1
15.6
10.0
59.7

13.4

17.8
50.0

7.6
62.4
26.8

14.6
20.4
29.9

22.9
29.0
2.5
5.6
4.5
4.1
3.5

4.1

6.4
9.6

15.3

66.2
102.5
33.8
66.2
89.8
59.2
25.5
32.5
26.8
96.0

49.1
50.7

>127

57.0
34.1
30.9
10.7
54.7

16.6

15.6
4.7
5.3
7.3

4.8
7.6
10.2

30

4.4
5.7
5.1
4.4
10.8
1.9
3.8

6.1
5.3
8.0
7.3
6.6
16.7
17.3
14.7
6.0
4.4
14.0

6.4

16.7
14.7
6.0
4.0
6.4
21.0

~lean

4.7

9.4

6.6

13.2

standard
deviation

1.6

5.6

2.7

6.8

20
21
22

23
24
25
26

27
28

29

of
10 normal

7.6
8.3
8.9 .

7.6
6.4
19.1

2.5

6.0

a See text for identification of patients.

,b Underlined values are greater than 2 standard deviations
above the normal mean.

TABLE 11
LEVEL OF SIGNIFICANCE OF DIFFERENCES
BETWEEN GROUPS BY THE MANN-WHITNEY TEST

Normals
Yeast

Mycelial
Cyto
Poly

Antigens

Cyto

Poly

Systemic
Patients

0.0089

0.0003

0.0268

<0.0001

0.0401

0.1210

0.1075

0.3859

Local and
Mucocutaneous Patients
Yeast
Mycelial
Cyto
Poly
Cyto
Poly
0.0655

0.0004

0.0409

<0.0001

Local and

Mucocutaneous
Patients

~
~

TABLE 12
NUMBERS OF PATIENTS WITH QIF VALUES GREATER
. THAN 2 STANDARD DEVIATIONS ABOVE THE
NORMAL MEAN WITH EACH ANTIGEN

in
Group

l~o.

Group

Antigen

Yeast
Cytoplasmic
Polysaccharide

Mycelial
Cytoplasmic
Polysaccharide

Systemic
Patients

14

6

9

9

13

Local and
11ucocutaneous
Patients

14

3

1

2

3

Normals

10

1

o

1

o

0"\
'-J
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detected in the indirect immunofluorescence test which had
previously been used in these studies.

Three out of 17 pa-

tients in the vaginal candidiasis group showed precipitating antibodies to the commercially prepared extract but
none demonstrated precipitating antibodies to purified man-

nan.
Quantitative immunofluorescence, using polyvalent
antisera to human immunoglobulins, was used to test the sera of 16 patients with Candida vaginitis for antibodies to
the purified yeast polysaccharide antigen.

Table 13 shows

the detected levels of antibody, expressed as a percentage
of the maximum reading found with a highly positive control
sera, and the mean level found in ten normal controls.
statistical comparison of the antibody levels in the patient and normal groups

1

using the Mann-Whi tlley test,

showed that the means of the two groups differed at a level
of p - 0.0778.

If P < 0.05 is chosen as the level neces-·

sary for statistical significance, the antibody levels in
these two groups do not show a significant

differer~ce.

Eight of the patients had antibody levels greater
than one standard deviation above the mean level of the

normal controls (that is above 15%).

Quantitation of anti-

body of the IgG class and the IgA class was done in these

patients using monospecific antisera to human IgG and IgA
in the fluoroimmunoassay.

Results (Table 13) showed the

antibody to be predominantly IgG in all cases.
Indirect immunofluorescence was done on these

bY

same eight sera, with the serum from a systemic candidiasis
patient used as a positive control and serum from a normal
individual used as a negative control.

The intensity of

fluorescence with fluorescein-labeled anti-human IgG following incubation with a vaginal candidiasis patient's
serum was indistinguishable from the intensity with the
systemic candidiasis patient's serum (Figure 3).

Intensity

with fluorescein-labeled anti-human IgA was definitely
less than that with anti-IgG, and less than that of the
systemic candidiasis patient with anti-IgA.

The normal

showed only a trace. of fluorescent staining with anti-IgG
and was negative with anti-IgA.
These studies on vaginal candidiasis patients
served not only to support the earlier data (90) that had
indicated that anti-candida antibodies in vaginal candidiasis patients were predominantly IgG but also to demonstrate
the usefulness of the QIF assay to achieve a number of
different goals in antibody detection.

Not only can the

presence and concentration of antibody be determined, but
their class is easily defined as well.

IV.

Antigen Detection Studies
Having completed these studies of detection of

antibodies to Candida albicans, our attention was turned
to attempts to detect circulating antigen.
In order to have sufficient amounts of sera,
which should contain circulating antigen, for the investi-

7Q
TABLE 13

RESULTS OF STUDIES USING QUANTITATIVE IMMUNOFLUORESCENCE
AND INDIRECT IMMUNOFLUORESCENCE TO DETERMINE LEVELS AND
CLASS OF ANTI-CANDIDA ANTIBODIES IN VAGINAL CANDIDIASIS
PATIENTS
QIF
lIE
TOTAL
IgG
IgA
IgG
IgA
ANTIBODY ANTIBODY ANTIBODY

PATIENT

P.B.

6.1%

s.s.

36.3%
0.3%

R.P.
D.B.

8.0%

S.G.
M.D.

7.3%

H.M.

c.w.

N.D.

N.D.

8.6%

3+

N.D.

N.D.
N.D.

6.6%

N.D.

N.D.·

16.7%~

7.5%

4.5%
1.2%

17.3%*
14.7%

C.H.
G.B.
P.D.

N.D. (1)
15.2%
N.D.
N.D.
N.D.
6.2%

N.D.
N.D.
N.D.
N.D.

3+
3+

N.D.
2+

N.D.
N.D.
N.D.
N.D.

1+
1+
N.D.

N.D.
N.D.

N.D.
N.D.

4.3%

3+

5.2%
3.4%
2.7%
5.2%
N.D.

3+

1+

3+

M.B.
W.B.

N.D.
N.D.
4.9%
27.7% 14.6%
18.7%* 10.3%
20.3% 10.7%
8.5%
17.7%
23.3% 11.1%
N.D.
4.7%

1+
1+
1+
N.D.

Mean
Standard Deviation

14.7%
9/4%

4.4%
2.2%

M.E.
A.C.

C.M.

10.5%
3.2%

2+
3+

N.D.

N.D.

1+

(2 )
Mean o.f 10 Normals

Standard Deviation
(l)N.D.

= Not

9.4%
5.5%

Done

(2)Three were positive by eIE; the sera from an asymptomatic donor found to have high antibody titers was not
included in this series.

(*)Positive by eIE.
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Figure 3

Indirect immunofluorescence on C. albicans cells:
(A) sera of a systemic candidiasis patient followed by

fluorescent anti-human IgGi (B) sera of a systemic candidiasis patient followed by fluorescent anti-human IgA;
(e) sera of a vaginal candidiasis patient followed by

fluorescent anti-human IgG; (D) sera of a vaginal candidiasis patient followed by fluorescent anti-human IgA.
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gation of these assays, Candida endocarditis was induced
irl 13 rabbits as described in Materials and !'1ethods. Nine
were infected with 10 6 Candida cells, two with 10 7 and two
with 10 8 .
2~

Rabbits were bled prior to infection, four at

hours post-infection, and all on days one and two

post-infection and every two to three days thereafter

until death or sacrifice.

To determine the extent of

infection achieved in these rabbits, blood cultures were
done each tinle the rabbi ts were bled and tissue was cuI tured
and examined grossly and microscopically at death or

sacrifice of the animals.
and pathology results.

Table 14 summarizes the culture

All blood cultures were negative

except the samples drawn at

2~

hours post-infection.

Four

out of four rabbits cultured at this time grew out yeasts
that were too numerous to count on the culture plate.
Gross examination of the hearts of the animals revealed
vegetations on the aortic valves and/ or the ventricles of

all rabbits except one which died two days post-infection.
Another which died within 24 hours showed damage to the

valves but no truly significant vegetations.

Figure 4

shows a vegetation from the left ventricle of one of the
infected rabbits.

Gross examination of the kidneys revealed

microabscesses and/or infarcts in all animals except the

ones which died within 24 hours and at two days.

Eight of

the 13 rabbits had positive cultures from the cardiac
vegetations and nine had positive cultures from the kidneys.

Microscopic evidence of Candida growth was seen on sections
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taken from the hearts of six rabbits.
example of what was seen.

Figure 5 is an

Microscopic evidence of Candida

growth was seen on sections taken from the kidneys of
three animals.

Figure 6 is an example of a rabbit kidney

in which organisms are seen in tubules.
From the evidence shown above, it seems obvious
that at least 10 of the 13 rabbi ts in whom indl1ction of
Candida endocarditis was attempted developed disseminated
disease.

Therefore, their sera should have provided a

good source of material in which to detect circulating
antigen.

We used counterimmunoelectrophoresis as described

in Materials and Methods to test each sample from these
rabbits and were unable to detect antigen in any of them.
In addition, the QlF inhibition assay for antigen was used
to test some samples.

A standard curve as seen in Figure

7 was obtained wi th a kno·wn antigen solution, but no

samples of rabbit sera showed any inhibition at all.
A limited number of patient samples were tested
for antigen by ClE, QlF inhibition, and ELISA inhibition.
Eight were tested by elE including five classified as
having systemic candidiasis and three with local or mucocutaneous candidiasis.

No antigen was discovered in the sera

of any of these patients, although elE showed one patient
to have antigen present in his joint fluid.
The QIF inhibition assay was used to test the
sera of 12 normals and eight patients including four
classified as having systemic candidiasis and four with

TABLE 14

CULTURE AND PATHOLOGY RESULTS ON RABBITS INFECTED WITH
CANDIDA ALBICANS
Gross Organ
No. of Days Lived Involvement
Infecting
Post
Rabbit organisms Infection Heart Kidney
1
2
3

4
5
6

7
8
9

10
11

12

13

10 88
10 7
10 7
10 6
10 6
10 6
10 6
10
6
10 6

10 6
10 6
10 6
10

1

7
21
21
2
29

18
24
29

31
32

38
29

+
+

+

-+

+

+
+

+
+
+
+
+
+
+

+
+
+
+
+
+
+
+

-+

Microscopic
Presence of
Organisms

Culture
Results
H~art

+

+
+
+

-

+

-

Kidney Heart Kidney
+

+

+
+

+
+
+

-

+
+

+

+

+

-

+

+

+
+

+
+

+
+

+

Figure 4

Left ventricular vegetation seen in a rabbit injected
with 10 6 Candida albicans cells.
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Figure 5

Candida organIsms seen In a microscopic section of a
cardiac vegetation from a rabbit infected with 10 6 Candida
cells.

78

Figure 6
Kidney section from a rabbit infected with 10 6 Candida
albicans cell.
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local or mucocutaneous infection.

These sera were all

treated as described in Materials and Methods to break up
any antigen-antibody complexes and destroy any free antibody.
For each sera a control was run to be certain that no free
antibody remained to interfere with the inhibition assay.
The percentage irlhibition of each sera can be seen in

Table 15 and comparison of the normals and patients reveals
no signif.icant difference.
table in

L~ese

Antigen waSt therefore, undetec-

samples by this method.

The ELISA inhibition assay was used to test ten
Ilormals and these same eight patients.

treated as above.

The sera were

An inhibition curve with standard

amounts of antigen can be seen in Figure 8.

The amount of

inhibition seen with normals and patients is seen in Table
16.

Again the difference between patients and normals was

insignificant and no antigen could be detected by this
method.
We also tried to determine the effect of the sodium

hydroxide treatment on

c.

albicans polysaccharide antigen.

For this serial dilutions of purified antigen were added
to a fixed volume of normal human serum and the mixture
was submitted to the treatment as suggested by Segal, et
al. (57) and described in Materials and Methods.

When the

treated mixture was tested in the QIF inhibition assay,
the standard inhibition curve normally seen with such
serial dilutions of antigen was not obtained.

81

TABLE 15
RESULTS OF THE QIF-INHIBITION ASSAY FOR ANTIGEN DETECTION
Patients a

% Inhibition

Normals

% Inhibition

1

10.7

1

0

2

5.8

2

0

3

0

3

0

4

2.9

4

2.1

5

0

5

5.2

6

0

6

10.3

7

1.0

7

17.5

8

0

8

9

12.6

10

2.9

11

1.0

12

0

a Patients 1-4 were diagnosed as having syst,emic
candidiasis.

0
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Figure 8

standard curve for the ELISA inhibition assay for
Candida antigen.

'0.1

1.0

0.8

.A.bsorbance
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··
0.6
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o.~
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TABLE 16
RESULTS OF THE ELISA INHIBITION ASSAY
FOR ANTIGEN DETECTION
Normals

% Inhibition

Patients a

% Inhibition

1

5.3

1

0

2

0

2

2.2

3

0.5

3

9.3

4

0

4

14.3

5

11.8

5

3.4

6

11.2

6

14.8

7

11.8

7

5.3

8

12.3

8

14.9

9

11.0

10

15.3

a Patients 1-4 were diagnosed as having systemic
candidiasis.
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v.

Immune Complex Studies
Because of the lack of success with these antigen

detection techniques, our attention was focused on investigation of the possibility that circulating immune complexes
might be present in the sera of systemic candidiasis patients and that they might be interfering with antigen
detection.

Sera from eleven patients in our group with

disseminated candidiasis and from 18 normal cont.rols was
tested by four immune complex screening tests - the Direct
Laser Nephelometry test, the PEG-C 4 , the PEG-IgG and the
C1q tests. The scores on the individual tests were compared for the two groups and, after the individual scores
were compiled into Ie scores, those, too, were compa.red

for the two grQups.

A statistically significant difference

(p < 0.05) was found between the patient and normal populations for three of the four screening
c1q assay) and with the

Ie

m~thods

(all but the

scores (Table 17).

with the results of these screening tests substantiating the existence of circulating immune

cor~~plexes

in the sera of patients with systemic candidiasis, attempts
were begun to isolate and characterize the complexes from
several patients.
Sera from four patients from our group with
systemic candidiasis, from one patient with a severe and
chronic mucocutaneous candidiasis, from one normal individual,
and from aIle patient wi th vasculi tis who had high immune
complexes and no sign of any Candida infection were analyzed.
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Immune complexes were isolated as described ln Materials
and Methods_

A characteristic profile from an ACA 34 sep-

aration of the PEG precipitate of the sera of a patient
with systemic candidiasis is shown in Figure 9.

Peaks 1,

the high molecular weight peak, and 2, the low molecular

weight peak/ were pooled and analyzed for the presence of
Candida antigen/ anti-Candida antibodies, IgG, IgM/ IgA,
cIg, C3 , and c 4 - The high molecular weight peak was
applied to a Sepharose 4B-Protein A column and eluted

first with PBS to obtain the bound protein fraction.

The

bOl1nd fraction was assumed to contain IgG which had stuck

to the Protein A.

10.

An elution profile is seen in Figure

These fractions were analyzed as had been the ACA

peaks.
Table 18 shows the results of the analysis of
the isolated fractions of patient and control sera.
Samples 1-4 were obtained from patients classified by our
criteria as having systemic candidiasis.

Sample 5 was

from a patient wi th severe and chronic mucocutaneol"'_S
candidiasis.

Sample 6 was obtained from a normal individual

with no sign of any Candida infection.

Sample 7 was from

a patient with vasculitis who had elevated circulating
immune complexes but no evidence of Candida infection.
Analysis of the sera of all the investigated individuals
showed no evidence of antigen by counterimmunoelectrophoresis
but antibody was present in all sera except the normal
individual by both eIE and quantitative immunofluorescence.
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TABLE 17

LEVELS OF CIRCULATING IMMUNE COMPLEXES IN SYSTEMIC
CANDIDIASIS PATIENTS BY FOUR SCREENING TECHNIQUES
(DIRECT NEPHELOMETRY, c 1 q ASSAY, C~ ASSAY AND IgG ASSAY)
AND A COMB lNED SORE

Patlent

DL

C1q

C4

IgG

IC Score

1

17

79.1

42

0.45

3.1700

2

18

99.5

41

0.70

2.6367

3

4

109.2

28

0.30

0.7756

4

8

75.6

0.64

1.6741

5

5

42

0.45

2.27.91

6

8

138.0

35

0.22

1.8800

110.0

23

0.42

1.9611

7

12.5

8

6

89.9

34

0.78

3.1686

9

0

101.6

39

0.39

0.9762

10

0

105.0

20

0.77

1.3651

11

5

126.8

0

0.13

0.0084

Mean of the
Patients

7.59

103.47

30.4

0.48

1.8086

Mea.n of 18
Normals

2.3

100.0

19.23

0.21

0.0433

0.1635

0.0068

0.0001

<0.0001

P Value of
Significance
of Difference
Between Patients
and Normals

0.0057
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~~en

the ACA 34 peaks were analyzed, anti-candida antibody

was found in the low molecular weight fraction of all
those examined except the normal and sample 7 and in the
high molecular weight fraction of all except the normal
and sample 1.

Sample 1 was the first sera tested and was

less extensively analyzed, having been tested for antibody
only by CIE, which is less sensitive than QIF, and having
not been analyzed for immunoglobulin or complement components.

Analysis of the ACA peaks by CIE for antigen,

however, revealed its presence in the high molecular
weight fractions of samples 2 and 5 and in the low molecular
weight fractions of samples 1 and 2.

Figure 11 is a

photograph of the CIE plate testing sample 2's fractions
for antigen.
Analysis of the ACA 34 fractions for immunoglobulin and complement components was done by immunodiffusion.
The analysis of sample 4 is shown in Figure 12 as an example.

The three systemic candidiasis patients tested, the

mucocutaneous patient, and the patient with

vascul~tis

all

had three immunoglobulin classes present in the high
molecular weight fraction while the normal individual had
evidence only of IgM.

Complement components were found In

the high molecular weight fraction only in the patients
with systemic

c~ldidiasis.

Analysis of the bound and unbound fractions from
the Protein A column separation of the high molecular
weight peaks of each sera revealed antibody in the bound
fraction only of samples 2, 3, and 5, two of which were
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Figure 9

Elution profile from ACA 34 column of 5% PEG precipitate of serum from a patient with systemic candidiasis.

Abs
1.0

0.5

n
70

80

90

1 0

Fractions

120

1 0

'140

89

Figure 10

Elution profile from a Sepharose 4B Protein A column
to which the high molecular weight fraction of sera from a
patient with systemic candidiasis was applied.

Abs

0.2

0.1

o

5

10

Fractions

15

TABLE 18
RESULTS OF THE ANALYSIS OF FRACTIONS OF PATIENT
AND CONTROL SERA ISOLATED FOR II~NE COMPLEXES
Fractions Sera ACA-34 high mol. wt. frac.

ACA-34 low mol. wt. frac.

Samplea~Ag~Ao'Ag~~Ao----G' M-~-A--CIq~t3'~C~4--Ag-~- Ab-~

1

-

2

+

+

+

+

+

+

+

+

+

-----

+ +

+

+

+

-

+

+

+

+

-

+

+

+ + + +++ +

-

+

-

+

+

+

+ + +

+

+

+ + +

4

- +

+

+ + +

5

- + +

+

+ + +
+

+

+

-

-

+

+

+

+

+

+

Protein A unbound frac.
Ag Ab G M A Clq C3 C4

+
+

+ + +

- +

-

+

A 'Clq C3 C4

+

+

3

7

+

Cl(iC3-~-C4-Ag-AbG-M

-

+ +

6

G M A

Protein A bound frac.

+

+

-

+

+

-

++ +

-

+

---

+ +++

++-

-

-----

- -

+

-

+

-

-

+

---

-

+ - ++

a Samples 1-4 were from patients diagnosed as having systemic candidiasis.
Sample 5 was from a patient with severe and chronic mucocutaneous candidiasis.
Sample 6 was from a normal indiuidual.
Sample 7 was from a patient with elevated immune complexes and no sign of Candida infection.
\C

C
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from systemics and one from the mucocutaneous patient.
Antibody was found in the unbound fraction of samples 3 and
4 from systemics and in the sample from the patient with
vasculitis.

The latter fact, along with the evidence of

IgM and IgA in sample 7's unbound fraction but not IgG,
made it seem that the antibody to Candida which had appeared in his high molecular weight peak might have been
19M rather than an immune complex.

Antigen was found in

the bound fraction from samples 2 and 5 and in the unbound
fraction of samples 1 and 2.

Immunoglobulins G, M, and A

Here detected in the bound fraction of sample 5 and G and M

were found in the bound fraction of sample 4.

Immunodiffu-

sion may not have been sensitive enough to detect the
w~ount

of immunoglobulin in sample 2 although more sensi-

tive methods could detect specific antibody.

c1q was de-

tected in the bound fraction of samples 3 and 5 and C4 also
in

s~~ple

3, further substantiating the existence of immune

complexes in these patients.

The unbound fraction from

samples 2 and 4 contained G, M, and A and C4 in san.pIe 2
and C3 in sample 4.
The Protein A-bound fraction in sample 5 which

had been found to contain both antigen and antibody was
applied to another ACA 34 column, this time equilibrated
and eluted in an acid buffer to try to keep the antigen and
antibody dissociated.

The profile can be seen in Figure 13.

Antibody was found in Peak II by QIF and antigen was found
in Peaks III and V by CIE.

A reproduction of this eIE
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Figure 11

Counterimmunoelectrophoresis testing ACA 34 fractions
from a patient with s:ystemic candidiasis for Candida antigen ..
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Figure 12

Immunodiffusion to determine the immunoglobulin and
complement component content of the ACA 34 fractions from
the sera of a patient with systemic candidiasis.
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Figure 13

Elution profile of the separation on an acid ACA-34
column of the Protein A bound fraction from the high
molecular weight peak of a sera from a patient with severe
and chronic mucocutaneous candidiasis.
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Figure 14

counterimmunoelectrophoresis plate showing the detection of antigen in tb.e eluted tractions from the acid-ACA-34
separation of the patient with severe and chronic mucocutaneous candidiasis.
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plate can be seen in Figure 14.

The results of the data on separation and
characterization of immune complexes, though not totally
consistent

wiL~

respect to the finding of antigen and anti-

body in high molecular weight fractions of all sera, certainly suggests that complexes consisting of Candida antigen and antibody do exist in the sera of some patients.

Discussion

The value of the serological methods of diagnosing
disseminated candidiasis has been a point of controversy
since the first reports of detection of anti-c,andida antibodies in patients with systemic disease prompted hopes
that the presence of these antibodies could lead to a de-

finitive diagnosis.

Initially, the most commonly used

tests were for agglutinating antibodies.

Agglutinins are

found in a high percentage of individuals with systemic

candidiasis but they also occur in a large percen,tage of
individuals without evidence of Candida infec.tion.

Winner,

in 1955, (91) found agglutinins in 31.6% of 2,017 hospital
patients and Scuro and Perrone in 1959,

(9~)

found an inci-

dence of 42.1% in 301 subjects without evidence of candidiasis.

Agglutinating antibodies may be found in Even

higher percentages of patients with superficial forms of
Candida infection.

80% of patients with chroni..c mucocu-

taneous candidiasis were found by Lehner et al. (42) to be
positive when tested for Candida agglutinins.

Complement-

fixing antibodies have likewise been found in high percentages of normals and superficially infected patients.

In

the group of 301 normals tested by Scuro and Per'rone (92),
30.6% were positive by complement fixation and in a group

98

of 48 patients with Candida skin infections tested by Peck
et ale

(33), 75% were found to be positive.

Indirect fluorescent antibody to Candida has been
found less frequently in normal individuals.

In six

series of healthy donors (39, 93, 94, 95, 96, 97), only
two (39, 97) reported any incidence of positive reaction
and those were 18.8% and 16.0% respectively.

Among pa-

tients with superficial forms of candidiasis, however,
percentages were much higher - 64% in a series of 75
patients with oral candidiasis (93) and 51.4% in a series
of 37 with oral infections (95).
Precipitating antibodies have generally' been found to
be more specific for systemic candidiasis.

A number of

authors (39, 94, 97, 98) claim to have found no positive
reactors in normal individuals.

Others, however, have

found a low incidence - 10.4% of 604 individuals in a
study by Douchet and Muller (99) and 3.7% of 191 individuals in a study by Everall et ale

(100).

In patients with

superficial forms of candidiasis, again, the incidence of
positive reactors is high in some studies.

Stanley and

Hurley (101) found 34.4% of 125 pregnant women with vaginal
candidiasis to have Candida precipi tins in, th.eir sera.
Taschdjian et al.

(102) found an incidence of 25.5%

positives in 51 subjects with superficial candidiasis.
Questioning the value of these antibody detection
tests, therefore, appears to be justified in light of
their lack of specificity for systemic candidiasis.

A

better means of

identifying<·~'the

individuals

w'r1i!tc. deep-seated

infection, who must be treated aggressively, is obviously
needed.
Several authors have noted that quantitation of antibody concentration may be a means of achieving greater
differentiation between groups with and without systemic
candidiasis.

In agglutination, complement fixation and

fluorescent antibody assays, results are usually reported
in terms of titers.

Seeliger (103) noted that agglutinins

found in healthy individuals rarely exceed a titer of
1:160.

Coudert et al. (94) failed to demonstrate titers

greater than 1:40 in 217 individuals including 17 with
superficial candidiasis and 62 with noncandidal infections.
Taschdjian et ale (3) have summarized the results of five
studies (39, 42, 93, 94, 104) with indirect fluorescent
antibody and found that titers greater than 1:160 are
rarely encountered in healthy individuals.
The development of the quantitative immunofluorescence
assay 'provided a means of objective measurement of antiCandida antibodies whereby the hypothesis could be tested
that higher titers of antibody are associated with systemic
disease, whereas lower titers are found associated with
superficially infected patients and normal individuals
(45).

Results in two series of patients included in these

studies suggest that this hypothesis is valid.

In the

series of patients tested in the initial studies where a
commercial yeast extract was used as antigen, a difference
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between mean antibody levels in the group of systemic patients and the group of normal controls was found to be
significant at a level of p < 0.01.

In the series of pa-

tients tested against purified cell wall polysaccharide
antigens, the QIF assay was able to differentiate between
systemic patients and normals and, more importantly, between systemic patients and those with a superficial
infection at a level of significance of p < 0.0005.

If a

value greater than two standard deviations above the
normal mean is considered as a positive test, none of the
normals is positive when tested against ei the.r polysaccharide antigen while only one of the superficially infected
patients is positive with yeast polysaccharide antigen and
three are positive with mycelial polysaccharide.
The QIF assay could, therefore, offer a significant
improvement in specificity in the diagnosis of systemic
candidiasis through quantitation of antibody.
Another value of the QIF assay lies in its easy
adaptation for the detection of class of antibody.

We

were able to use the assay to test the hypothesis that
superficial forms of Candida infection involve the predominant production of IgA antibodies rather than. IgG.

Earlier

studies by Mathur et al. (32) using indirect immunofluorescence on smears of Candida cells to test the sera of
vaginal candidiasis patients had suggested that this was
the case.

Warnock et al.

(90), however, using the same

technique, disputed these findings and showed that the
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distribution of antibody In vaginal candidiasis patients'
sera was similar to that in systemic patients - that is,
predominantly IgG.

Our studies using QIF and indirect

immunofluorescence have confirmed the latter findings.
The differences in these studies may, possibly, be due to
differences in patient selection or to differences in the
specificity of the antisera.

In any event, it seems

evident that the initial impression that the assay of IgA
anti-candida antibodies could be of value in the diagnosis
of vaginal candidiasis cannot be sustained in light of the
present data.
Another suggested means of differentiating between
systemic candidiasis patients and other groups has been

tIle detection of antibodies to purified components of
Candida organisms.

Observations on the rapid phagocytosis

and breakdown of Candida organisms injected intravenously
(35, 105), assumedly resulting in the release of Candida
cell contents, have prompted the idea that antibodies to
cytoplasmic proteins might be more specific for disseminated
disease than antibodies to cell wall polysaccharide.
Prior to our efforts, studies using defined antigens
have been done using the precipitin reaction, as most

ag~

glutination and classical indirect immunofluorescence
tests use whole Candida cells as substrate and, thus,
detect anti-cell wall mannan antibodies.

Taschdjian et

al. (3) prepared a Candida extract, called the S antigen,
and used it in immunodiffusion.

Though the authors ha,\Te
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called i t a "cytoplasmic extract", they describe two
precipitin lines when the antigen is tested against rabbit
sera, one of which could be removed by absorption of the
antiserum with Candida spores.

This indicates that the

extract contains a cell wall component.

Precipitins

against both antigens were found in 83% of patients diagnosed as having systemic candidiasis but the same reaction
was found in patients with chronic cutaneous or mucocutaneous candidiasis associated with autoimmune

endo~rinopathy.

The authors claim that no reaction at all was demonstrated
in normals or patients with banal superficial candidiasis.
Hellwege et ale (106), using a similar antigen, however,
found false positive precipitin reactions in three of 93
healthy individuals and eight of ten patients with bronchial
asthma.
Buckley, Lapa, and Hipp (107) removed the polysaccharide from their extract by precipitation with concanavallin
A and eliminated the positive precipitin reactions of
eight patients with banal superficial candidiasis

~nd

three with allergic conditions, while five patients with
systemic candidiasis and two with chronic superficial
candidiasis reacted with the protein fraction.
et al.

Syverson

(75) found 33 of 271 hospitalized patients without

evidence of deep candidal infection, six of 22 vaginal
candidiasis patients, and ten of 41 patients with other
fungal infections to have positive precipitin reactions
with an extract containing polysaccharide.

After purifica-
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tion of the antigen on Con A, only six of the hospitalized
patients, none of the vaginal candidiasis patients, and
two of the patients with other fungi reacted.
In our studies we have also shown that precipitin re-

actions in normals and in patients with cross-reacting
fungi are indee.d due to the reaction wi th the polysaccharide component.

In contrast, precipitating antibodies to

purified cytoplasmic antigen were found only in patients
with systemic disease and in one patient with a long-standing chronic mucocutaneous candidiasis.

These results

confirm that when a qualitative test for precipitating antibodies is used, the use of purified cytoplasmic antigen
rather than a crude extract COlltaining cell wall polysaccharide, provides a much more specific test for systemic
disease.

There is, however, some lack of sensitivity

since three of a total of 12 (Series I and II) patients
with systemic disease did not have anti-yeast cytoplasmic
antibodies and eight of 21 patients did not have anti-mycelial cytoplasmic antibodies.

This may be partly due to

these patients having been infected with strains of Candida
other than albicans as was true with five of our negative
patients who had been infected with

c.

tropicalis.

But,_

since three others were also negative, the difference in
strains does not entirely account for the lack of sensitivi-

ty.

Testing against cytoplasmic extracts from various

strains, however, might lead to some improvement.
Our QIF assay has allowed us to combine a quantitative
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assay with the use of purified antigens and has resulted
in our finding that antigens containing cell wall polysaccharide can be much more valuable in a quantitative than a
qualitative assay.

statistically, excellent differentia-

tion between systemic patients and normal or superficially
infected patients is obtained with yeast
mycelial

(p <

(p < 0.004)

0.001) polysaccharide antigens.

and

The speci-

ficity of the test appears better with yeast polysaccharide
antigen since only one out of 15 superficially infected
patients and no normal has a value greater than two standard
deviations above the normal mean.

.with

myce~ial

poly-

saccharide, three superficially infected patients have
significant levels of antibody.

with regard to sensitivity,

however, mycelial polysaccharide appears better since 13
of 14 systemic patients have significantly elevated antibody

values while nine of 14 are positive with yeast polysaccharide.
When QIF is done using cytoplasmic antigens, the
specificity is not as great as it appeared with ClE,
possibly because this technique is more sensitive qnd so
detects lower levels of anti-cytoplasmic antibody which
may be present in less severely infected individuals.
However, all the patients with systemic candidiasis still
do not have evidence of anti-cytoplasmic antibodies even
with this technique.

A

compromised level of immunocompe-

tence in these patients could possibly account for this.
In summary, our data on the detection of antibodies
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to Candida suggests that both approaches, quantitation of
antibody and purification of antigen , can result in improvements in the value of these tests in the diagnosis of
systemic candidiasis.

If a qualitative precipitin tech-

nique is used, the use of cytoplasmic antigens provides a
test more specific for systemic disease.

If a quantitative

test is used, however, the purification of the antigens is
less essential as adequate differentiation between deeply
infected patients and others can be attained by antigens
containing cell wall polysaccharide.

In fact,

there seems

to be more overlap between groups when the cytoplasmic antigens are used in the quantitative technique.
It has also been suggested (45) that, since the mycelial form of Candida albicans is thought to be associated
with severe infections as opposed to saprophytic colonization, mycelium specific antigens might also be more specific for disseminated disease.

However, our study has not

been able to clearly define the value of the mycelial
growth

pha~e

antigens as opposed to yeast phase antigens.

Although more of the systemic patients were found to be
positive with mycelial antigens than with yeast antigens,
there also were more positive results with these antigens
and superficially infected patients.

This question remains

open for discussion.

It seems apparent that an absolute diagnosis of systemic candidiasis cannot be accomplished through antibody
detection techniques even though their value is improved
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by quantitation and antigen purification.

Many investigators (51, 52, 53, 54) have, therefore,
turned to detection of circulating antigen as a possible
means to achieve a more absolute diagnosis.

Although some

have claimed a degree of success, others (55, 56) have
questioned the helpfulness of these assays.

Our difficul-

ties in attempting antigen detection lead us to support
the latter group_
Several ideas have been offered to explain the difficulties with antigen detection.

Lehman and Reiss (55)

have suggested that one problem may be the existence of
major differences in the sensitivity of

anti~mannan

to the two serotypes of c. albicans mannan.

sera

They also

have observed temperature sensitivity which may affect the
success of the tests, especially when ELISA is used.
Studies by Warren et ale

(108) showed that antigen was not

detectable when the antibody used was anti-mannan IgG from
immunized rabbits but that IgG from rabbits convalescing
from disseminated candidiasis was capable of detecting
antigen in the sera of lethally infected rabbits and mice.
This suggests that some antigen other than mannan may be
what is detected.

Jones (56) suggests that the limits of

detection of the available assays may not be adequate to
detect extremely small levels of antigen present in the
sera of infected individuals since declaring a serum
positive becomes extremely difficult when detection of a
concentration < 100 ng/ml is necessary.

Jones found that
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cell wall mannan

18

cleared very rapidly from the blood

and that a disseminated infection with a very large number
of organisms (~ 10 9 ) would be necessary to reliably produce
a mannan concentration> 100 ng/ml in the sera of rabbits.
When such a large number of organisms is used to induce
infection, the inoculum is uniformly lethal in less than
24 hours so that meaningful studies cannot be done.

Our

work agrees with this since three rabbits injected with
10 9 organisms and one of two infected with 108 died within
24 hours.

Jones further suggests that ~ 10 10 Candida

would be reqllired to produce > 100. ng/rnl of mannan in
human serum.
Finally, those authors (53, 57) who have been success-

ful in detecting circulating antigen have often found it
necessary to pretreat the sera in such a way that antigen
would be released from antibody.

Weiner and coats-Stephen

(53) noted that none of 17 rabbit sera not subjected to

dissociating condi tions had detectable antig"e.n but all had
detectable antigen after heat extraction of serum bound
antigen.

However, our experiments with a sodium hydroxide

treatment of mixtures of normal serum and purified antigen
indicate that subjection of serum to dissociating conditions
can result in denaturation of antigen and interference
with detection assays.

It seems logical to conclude that

milder and safer techniques to dissociate antigen-antibody
complexes may need to be developed for antigen detection
to become a routine assay.
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On the other hand, though much has been assumed about

the presence of immune complexes in candidiasis patients'
sera, no hard evidence of their existence has been presented until this time.

Results of the screening tests which

were performed in our group of disseminated candidiasis
patients indicated a statistically significant difference
did exist in the levels of complexes in this group and a
group of normals.

Isolation and characterization of the

complexes from five patients substantiated the presence of
anti-candida antibody and/or Candida antigen in complexes
of at least three of them.

In the.other two, it was less

certain as the antibody or antigen was found in the fraction
which did not bind to Protein A rather than in the IgG
containing fraction that did bind.

However, Candida

antigen or antibody was found in the high molecular weight
fraction of these sera and antibody might have been of a
class other than IgG or of subclass IgG3 which would not
have bound to Protein A. The presence of complement
components in the high molecular weight fractions and the
Protein A bound fractions of these sera further substantiated the existence of immune complexes.
These results provide support for the view that
circulating immune complexes containing microbial antigen
do exist in systemic candidiasis and, therefore, may
indeed be one reason for difficulties in detecting Candida
antigen since a variable fraction of the antigenic determinants of circulating antigen will be uhidden u by binding
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to antibody molecules.

In addition to their significance

with respect to antigen detection

l

any possible role of

immune complexes in the pathogenesis of the disease is unknown.

There is no evidence for any immune-complex-media-

ted vasculitis or glomerulonephritis as is seen in the
renal lesions of malaria (109) and in post-streptococcal
glomerulonephritis (110).

Another possibility, which has

been suggested in coccidioidomycosis (10), is that the

role of immune complexes might be related to their potential
immunosuppressive effects.

Immune complexes have been

shown to depress T cell-mediated delayed type hypersensitivity (11) and cell-mediated cytotoxicity (112), and to
suppress the chemotactic response of polymorphonuclear
neutrophils (113).

Considering the importance of phagocytic

cells of the body in ingesting Candida and of the cellular
immune response in defense against fungal infections, it
seems possible that immune complex-mediated suppression of
the immune response might have an adverse effect on the
course of the disease.

This is an

in~eresting

hypothesis

that may be pursued now that the presence of the immune
complexes has been established.
In summary, our studies on the immunological approach

to the diagnosis of systemic candidiasis have resulted in
several findings.

The development of a quantitative immu-

nofluorescence method of antibody detection provides an
improved diagnostic test for systemic candidiasis.

Our

studies on the relative merits of cytoplasmic and polysaccha-
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ride antigens of the yeast and mycelial phases of Candida
growth have supported the idea that cytoplasmic antigens
are more valuable in qualitative tests while polysaccharide
antigens may be adequate in

gu~ntitative

tests.

Finally,

our substantiation of the existence of circulating Candidaanti-candida immune complexes in the sera of patients with
severe candidiasis supports the theory that these immune
complexes may be part of the problem with developing a reliable antigen-detection assay and provides a hypothetical
mechanism for the suppression of the cellular immune response which may be involved with the progression of the
disease.

III
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